glucaric acid has been researched along with ferric oxide, saccharated in 490 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 54 (11.02) | 18.7374 |
1990's | 38 (7.76) | 18.2507 |
2000's | 193 (39.39) | 29.6817 |
2010's | 202 (41.22) | 24.3611 |
2020's | 3 (0.61) | 2.80 |
Authors | Studies |
---|---|
Glassman, E | 1 |
Ciuffi, M; Franchi-Micheli, S; Gentilini, G; Zilletti, L | 2 |
Balling, A; Hausmann, K; Kuse, R | 1 |
Casciani, CU; Di Nucci, G; Elia, L; Mandelli, F; Mariani, G; Meloni, C; Piazza, A; Taccone-Gallucci, M; Torromeo, C; Valeri, M | 1 |
Imamura, K | 1 |
Fridrich, R; Mueller, RM; Oberhaensli, RD | 1 |
Furukawa, K; Higashi, T; Kobayashi, M; Otsuka, H; Wakao, H | 1 |
Fujita, I; Hara, K; Hirota, M; Ito, N; Nagasawa, M; Nakatomi, M; Nasu, M; Saito, A; Shigeno, Y; Tanaka, H; Yamaguchi, K | 1 |
Fuchigami, T; Iida, M; Imamura, K; Okada, M; Omae, T | 1 |
Takishima, T; Tanno, Y | 1 |
Fuchigami, T; Fujita, K; Iida, M; Imamura, K; Murakami, M; Nanishi, F; Ogawa, K; Ohgushi, H; Okada, M; Omae, T; Yao, T | 1 |
Ito, T; Takemori, N | 1 |
Ageeva, TA; Shkurupiĭ, VA | 1 |
Wiśniewska-Knypl, JM; Wrońska-Nofer, T | 1 |
Fukaya, S; Imamura, T; Iwamoto, T; Kanou, H; Konjiki, O; Takasaki, M | 1 |
Irimajiri, S; Matsuoka, Y; Ohoike, H; Suzuki, A | 1 |
Fehr, J; Höchli, P; Wagenhäuser, FJ | 1 |
Blum, M; Frank, N; Iaina, A; Kaplan, E; Levi, BA; Peer, G; Silverberg, DS; Steinbruch, S | 1 |
Mercuriali, F | 2 |
Tryba, M | 1 |
Commerford, A; Haworth, C; Meyer, JH; Meyer, MP | 1 |
Danielson, BG; Derendorf, H; Geisser, P; Salmonson, T | 1 |
Blum, M; Iaina, A; Kaplan, E; Peer, G; Silverberg, DS | 1 |
Abbas, M; Abotalib, Z; al-Meshari, A; al-Momen, AK; al-Nuaim, L; Khashogji, T; Saddique, A | 1 |
Hörl, WH; Sunder-Plassmann, G | 2 |
Bowen, WH; Miguel, JC; Pearson, SK | 1 |
Hörl, WH; Spitzauer, S; Sunder-Plassmann, G | 1 |
Cynke, E | 1 |
Cazzola, M | 1 |
Akcicek, F; Atabay, G; Basci, A; Celik, A; Cirit, M; Ok, E; Ozkahya, M; Toz, H; Unsal, A | 1 |
Abdalla, AH; al-Hawas, F; al-Khader, AA; al-Sulaiman, MH; Mousa, DH; Popovich, W | 1 |
Bernière, J; Dehullu, JP; Gall, O; Murat, I | 1 |
Nonaka, D; Okamura, T; Takaki, K; Taketa, H; Tanaka, M; Umeno, M | 1 |
Andrade, S; Colaço, S; Oliveira, C; Ponce, P; Santos, JP; Silva, J; Ventura, H | 1 |
Sato, K; Shiraki, M | 1 |
Antoni, G; Beshara, S; Danielson, BG; Långström, B; Lubberink, M; Lundqvist, H; Sundin, J; Tolmachev, V; Valind, S | 2 |
Atherton, DJ; Cox, I; Hann, I | 1 |
Eckstein, R; Glaser, A; Lauer, G; Rippel, R; Skoda, P; Weisbach, V; Zimmermann, R; Zingsem, J | 1 |
Dejaco, C; Fueger, GF; Gangl, A; Gasche, C; Lochs, H; Reinisch, W; Tillinger, W; Waldhoer, T | 1 |
Claris, O; Picaud, JC; Putet, G; Salle, BL | 1 |
Breymann, C; Huch, A; Huch, R; Hüttner, C; Krafft, A | 1 |
Asano, T; Baxter, JG; Maebashi, N; Yamaguchi, T | 1 |
Kho, B; Lim, PS; Wei, YH; Yu, YL | 1 |
Beshara, S; Lubberink, M; Lundqvist, H; Tolmachev, V | 1 |
Bailie, GR; Johnson, CA; Mason, NA | 1 |
Descombes, E; Fellay, G | 1 |
Adhikarla, R; Cavallo, G; Charytan, C; Gagnon, S; Levin, N; Spinowitz, BS; Van Wyck, DB | 1 |
Breymann, C; Huch, A; Huch, R; Krafft, A | 1 |
Grönhagen-Riska, C; Parkkinen, J; Peltonen, S; Rosenlöf, K; von Bonsdorff, L | 1 |
Chang, HY; Chen, KS; Kao, HH; Lee, CC; Tsai, CJ | 1 |
Hayde, M; Hayn, M; Herkner, K; Lombard, KA; Lubec, G; Pollak, A; Weninger, M; Widness, JA | 1 |
Al-Saloum, M; Charytan, C; Gagnon, S; Hafeez, T; Levin, N; Van Wyck, DB | 1 |
Kosch, M; Schaefer, RM | 2 |
Breymann, C; Huch, A; Huch, R; Visca, E | 1 |
Agbaria, Z; Baruch, R; Blum, M; Deutsch, V; Iaina, A; Irony, M; Schwartz, D; Silverberg, DS; Steinbruch, S; Yachnin, T | 1 |
Inglis, H; Newstead, CG; Stoves, J | 1 |
Bahner, U; Bettger, H; Kosch, M; Matzkies, F; Schaefer, RM; Teschner, M | 1 |
Feichtenschlager, T; Gasche, C; Male, C; Mayer, A; Mittermaier, C; Petritsch, W; Waldhoer, T | 1 |
Chandler, G; Harchowal, J; Macdougall, IC | 1 |
Gottschalk, R; Kaltwasser, JP; Kessler, U; Möller, B; Stucki, G | 1 |
Duffy, CI | 1 |
Agullès, O; Bayoumeu, F; Laxenaire, MC; Vial, F; Zaccabri, A | 1 |
Hider, RC; Kooistra, MP; Marx, JJ; Rabelink, TJ; Rooyakkers, TM; Stroes, ES; van Faassen, EE | 1 |
Gosriwatana, I; Hider, RC; Kersting, S; Kooistra, MP; Lu, S; Marx, JJ; Nijhoff-Schutte, J | 1 |
Baruch, R; Blum, M; Iaina, A; Keren, G; Schwartz, D; Shaked, M; Sheps, D; Silverberg, DS; Steinbruch, S; Tchebiner, J; Wexler, D; Yachnin, T; Zubkov, A | 2 |
Canziani, ME; Draibe, SA; Manfredi, SR; Neto, MC; Rangel, EB; Yumiya, ST | 1 |
Baka, NE; Bayoumeu, F; Laxenaire, MC; Legagneur, H; Monnier-Barbarino, P; Subiran-Buisset, C | 1 |
Eran, A; Harmankaya, O | 1 |
Hanson, SY; Johnson, AC; Wasse, H; Zager, RA | 1 |
Breymann, C; Huch, A; Huch, R; Perewusnyk, G | 1 |
Froger, H; Gottrand, F; Guimber, D; Mention, K; Michaud, L; Neuville, S; Turck, D | 1 |
Chaimovitz, C; Mazor, D; Meyerstein, N; Tovbin, D; Vorobiov, M | 1 |
Oldham, FB | 1 |
Besarab, A; Yee, J | 1 |
Mushtaq, A; Wali, A | 1 |
Chuang, CL; Huang, TP; Liu, RS; Tarng, DC; Wei, YH | 1 |
Agarwal, R; Coyne, DW; Dahl, N; Folkert, VW; Michael, B; Myirski, P; Warnock, DG | 1 |
Antoni, G; Beshara, S; Danielson, BG; Långström, B; Lubberink, M; Lundqvist, H; Sörensen, J; Tolmachev, V | 1 |
Fishbane, S | 1 |
Edwards, JH | 1 |
Calişkan, S; Camsari, T; Cavdar, C; Celik, A; Onvural, B; Sifil, A; Temiz, A; Yeniçerioğlu, Y | 1 |
Albarracín, C; Fanlo, B; Junquera, E; Rodríguez Palomares, JR | 1 |
Blum, M; Iaina, A; Keren, G; Schwartz, D; Sheps, D; Silverberg, DS; Wexler, D | 1 |
Cohen, G; Deicher, R; Hörl, WH; Müllner, M; Ziai, F | 1 |
Acton, RT; Barton, JC; Coghlan, ME; Ozbirn, TW; Reymann, MT | 1 |
DESHMUKH, PL | 1 |
ASSALI, NS; NICHOLSON, DB | 2 |
NISSIM, JA | 2 |
DICKIE, W; HAGBERG, B; VAHLQUIST, B | 1 |
STILLE, G | 2 |
MEYER, F; STILLE, G | 1 |
PRIBILLA, W | 1 |
OVERKAMP, H | 3 |
HAGEN, A; LARSEN, V; LASSEN, N | 1 |
ARTETA, JL; PUCHOL, JR | 1 |
BENACERRAF, B; BIOZZI, G; HALPERN, BN; STIFFEL, C | 1 |
DEVOE, RW; MOSES, LE | 1 |
ELLIS, JT | 1 |
BUCHI, J; ZOPPI-HUG, R | 3 |
BENACERRAF, B; BIOZZI, G; STIFFEL, C | 1 |
FELLINGER, K; GISINGER, E; VETTER, H | 1 |
GAMERDINGER, G; PIETZONKA, H | 1 |
RICHTER, GW | 2 |
CIBIS, PA; YAMASHITA, T | 2 |
MOORE, RD; MUMAW, V; RUPP, J; SCHOENBERG, MD | 1 |
TRAUT, H | 1 |
GABBIANI, G; SELYE, H; VASKU, J | 1 |
MENZIES, DW; RYAN, GB | 1 |
MAGNANELLI, P; SALERA, U | 1 |
GARRISON, FE; HOBSON, JB; ITOGA, T; JONES, OW; LASZLO, J | 1 |
Bugat, R; Mourey, L; Séronie-Vivien, S; Tohfe, M | 1 |
Borisov, AV; Borisova, EV; Fesiuk, AF; Lovchinskiĭ, EV; Mordik, AI | 1 |
Avram, MM; Blaustein, DA; Chattopadhyay, J; Daoui, R; Gadh, R; Schwenk, MH; Singh, H | 1 |
Colfer, M | 1 |
Geisser, P | 1 |
Beshara, S; Danielson, BG | 1 |
Chernev, A; Chernev, T; Karag'ozova, Zh; Koleva, R | 1 |
Folkert, VW | 1 |
Breborowicz, A; Breborowicz, M; Polubinska, A; Tam, P; Wu, G | 1 |
Grabe, DW; Manley, HJ | 1 |
Anderson, J; Johnson, K; Van Wyck, D | 1 |
BENSLEY, EH; CAMERON, DG; GRAYSTON, V; WOOD, P | 1 |
BENSLEY, EH; CAMERON, DG; WOOD, P | 1 |
STRAHM, A; WALTER, F | 1 |
HOLLY, RG | 1 |
BERSIN, T | 1 |
BIERMAN, HR; BYRON, RL; KELLY, KH; WHITE, LP | 1 |
Al-Saloum, MM; Charytan, C; Schwenk, MH; Spinowitz, BS | 1 |
Blum, M; Iaina, A; Schwartz, D; Silverberg, D; Wexler, D | 1 |
Rodgers, GM; Silverstein, SB | 1 |
Goldenberg, H; Lutzky, B; Schaufler, R; Scheiber-Mojdehkar, B; Sturm, B | 1 |
Almer, S; Bodemar, G; Danielson, BG; Kechagias, S | 1 |
Hanson, SY; Johnson, AC; Zager, RA | 1 |
Derfler, K; Födinger, M; Hörl, WH; Jansen, M; Kletzmayr, J; Rainer, V; Sengoelge, G; Sunder-Plassmann, G | 1 |
Blumenstein, I; Dignass, AU; Jahnel, J; Schröder, O; Schrott, M; Stein, J | 1 |
Agarwal, R | 5 |
Aronoff, GR; Bennett, WM; Blumenthal, S; Charytan, C; Pennell, JP; Reed, J; Rothstein, M; Strom, J; Van Wyck, D; Wolfe, A; Yee, J | 1 |
Chester, K; McMahon, LP; Walker, RG | 1 |
Blaustein, DA; Schwenk, MH | 1 |
Eiam-Ong, S; Praditpornsilpa, K; Tiranathanagul, K; Tosukhowong, P; Tungsanga, K | 1 |
Cuenca Espiérrez, J; García Erce, JA; Martínez Martín, AA; Modrego Aranda, FJ; Solano, VM | 1 |
Cuenca, J; García-Erce, JA; Herrera, A; Izuel, M; Martínez, AA; Muñoz, M | 1 |
MEGASSINI, VE; MHANI, NO | 1 |
Abramowicz, P; Borawski, J; Gozdzikiewicz, J; Mysliwiec, M; Naumnik, B | 1 |
Bagdatoglu, O; Bali, M; Dhondt, AW; Guz, G; Kavutcu, M; Reis, KA; Sahinarslan, A; Sindel, S; Yalçin, R | 1 |
Abe, R; Horiuchi, T; Ogi, M; Wakabayashi, M; Wakabayashi, T | 1 |
Bozhinova, S; Ivanova, I; Lukanova, M | 1 |
El-Agroudy, A; El-Husseini, A; Hassan, N; Khalil, A; Sabry, A; Salem, A; Sheashaa, H; Sobh, M | 1 |
Cuenca, J; García-Erce, JA; Martínez, AA; Molina, J; Muñoz, M; Solano, VM | 1 |
Maslovsky, I | 1 |
Bailie, GR; Clark, JA; Lane, CE; Lane, PL | 1 |
Erturk, S; Keven, K; Kutlay, S; Nergizoglu, G | 1 |
Durandy, Y; Hulin, S | 1 |
Iida, M; Imamura, K; Okada, M; Okuda, S; Oochi, N; Sanai, T | 1 |
Dargan, PI; Jones, AL; Lawes, M; Thomson, AH; Wood, DM | 1 |
Macdougall, IC; Roche, A | 1 |
Zager, RA | 2 |
Berge, RK; Berstad, A; Erichsen, K; Hausken, T; Johansen, J; Nysaeter, G; Ostborg, J; Ulvik, RJ | 1 |
Collins, AJ; Obrador, GT; Roberts, TL; St Peter, WL | 1 |
Barut, Y; Eres, M; Gürsu, RU; Murat, B; Ozdemir, A; Selamet, U; Yalinbaş, B | 1 |
de Weerth, A; Dignass, AU; Herfarth, H; Junge, U; Mickisch, O; Reinshagen, M; Schreiber, S; Schröder, O; Schrott, M; Seidler, U; Stein, J | 1 |
Hörl, WH; Sengölge, G; Sunder-Plassmann, G | 1 |
Ahlmén, J; Chertow, GM; Mason, PD; Vaage-Nilsen, O | 1 |
Födinger, M; Hörl, WH; Mittermayer, F; Puttinger, H; Schaller, G; Scheiber-Mojdehkar, B; Sunder-Plassmann, G; Vychytil, A; Wolzt, M | 1 |
Martinez, CO; Mazey, RM; McMurray, S; Roppolo, M; Van Wyck, DB | 1 |
Laman, CA; Rodgers, GM; Silverstein, SB | 1 |
Govan, AD; Scott, JM | 1 |
Ghannam, M; Karkouti, K; McCluskey, SA; Quirt, I; Salpeter, MJ; Yau, TM | 1 |
Huang, X; Katz, SD; Zhang, Q; Zheng, H | 1 |
Anbu, AT; Bradbury, MG; Kemp, T; O'donnell, K; Smith, PA | 1 |
McLoughlin, P; Musthyala, R | 1 |
Karmiris, K; Kouroumalis, EA; Koutroubakis, IE; Makreas, S; Niniraki, M; Xidakis, C | 1 |
Cuenca, J; García-Erce, JA; Muñoz, M; Naveira, E; Palmer, JH; Seara, J | 1 |
Canser, E; Gilsanz, F; Gimeno, M; Gredilla, E; Martínez, B; Pérez Ferrer, A | 1 |
De Smet, R; Dhondt, AW; Glorieux, GL; Guz, G; Vanholder, RC; Waterloos, MA | 1 |
Barton Pai, A; Depczynski, J; McQuade, CR; Mercier, RC; Pai, MP | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Loh, PH; Tin, L | 1 |
Ambühl, PM; Binet, I; Dickenmann, M; Keusch, G; Lüthi, L; Schiesser, D; Schmidli, M; Tsinalis, D; Wüthrich, RP | 1 |
Alonzo, E; Bellorin-Font, E; Carlini, RG; Weisinger, JR | 1 |
Bartlett, FR; Bolger, AP; Chapman, CM; Kaprielian, R; O'Leary, J; Penston, HS; Pollock, N | 1 |
Cardona, R; Cuenca, J; García-Erce, JA; Martínez, F; Muñoz, M; Pérez-Serrano, L | 1 |
Bhandal, N; Russell, R | 1 |
Eiselt, J; Opatrný, K; Racek, J; Stehlík, P; Trefil, L | 1 |
Raja, R; Rizkala, AR; Sirken, G | 1 |
Breborowicz, A; Breborowicz, M; Górna, K; Oreopoulos, DG; Polubinska, A | 1 |
Gershanovich, ML; Livshits, ME; Makhnova, EV | 1 |
Juncà, J | 1 |
Cho, HJ; Kim, JH; Kim, JW; Kim, SH; Kim, SW; Kim, YT; Nahm, EJ; Yoon, BS | 1 |
Cuenca Espiérrez, J; García-Erce, JA; Gómez Barrera, M; Izuel Rami, M; Rabanaque Hernández, MJ; Villar Fernández, I | 1 |
Breymann, C; Canclini, C; Geisser, P; Stahel, M; von Seefried, B | 1 |
Boyd, AV; Harford, A; McQuade, CR; Norenberg, JP; Pai, AB; Zager, PG | 1 |
Camps, J; Ferré, N; Joven, J; Mackness, B; Mackness, M; Marcas, L; Marsillach, J; Martínez-Vea, A | 1 |
Das, J; George, P; Itty, C; Pawar, B | 1 |
Beck-da-Silva, L; Bocchi, E; Clausell, N; de Albuquerque, D; Montera, MW; Moura, LZ; Pereira-Barretto, AC; Rassi, S; Rohde, LE; Vilas-Boas, F | 1 |
Ranfaing, E | 1 |
Baribeault, D; Rosenberg, CL; Sane, R | 1 |
Deveci, M; Oymak, O; Sari, I; Sav, T; Sipahioglu, MH; Tokgoz, B; Utas, C | 1 |
Huch, R; Krafft, A; Schaefer, RM | 1 |
Breborowicz, A; Breborowicz, M; Oreopoulos, DG; Polubinska, A; Simon, M; Wanic-Kossowska, M | 1 |
Auerbach, M; Rodgers, GM | 1 |
Binder, T; Dvorská, M; Feldmár, P; Záhumenský, J; Zmrhalová, B | 1 |
Agarwal, R; Kaskas, MO; Minasian, R; Rizkala, AR; Trout, JR | 1 |
Vikrant, S | 1 |
Charytan, C; Reed, J; Yee, J | 1 |
Martinez, A; Thomas, J | 1 |
Cangiano, JL; Noble, S; Reed, J; Singh, H; Van Wyck, DB | 1 |
Agarwal, R; Bishu, K | 1 |
Breymann, C | 1 |
Grzegorzewska, AE | 1 |
Grekas, DM; Makedou, A; Makedou, K; Malindretos, P; Raptis, V; Rudenco, I; Sarafidis, PA | 1 |
Sato, K | 1 |
Di Gennaro, F; Duarte, P; Lombraña, A; Toblli, JE | 1 |
Francis, GS; Kanderian, A | 1 |
Geraci, G; Handelman, GJ; Kuhlmann, MK; Levin, NW; Wang, S | 1 |
Camsari, T; Cavdar, C; Cavdar, Z; Saglam, F; Uysal, S | 1 |
Enzmann, H; Langguth, P; Roth, S; Spicher, K | 1 |
NISSIM, JA; ROBSON, JM | 1 |
Pauly, RA; Wall, GC | 1 |
Boyd, A; Chan, LN; Norenberg, J; Pai, AB; Raj, D | 1 |
SLACK, HG; WILKINSON, JF | 1 |
Li, H; Wang, SX | 2 |
Jaber, BL | 1 |
Al Talib, K; Auerbach, M | 1 |
Allen, RP; Barker, PB; Beard, JL; Earley, CJ; Horská, A; Mohamed, MA | 1 |
Abraham, K; Ahmed, MS; Irvine, T; Lim, R; Wong, CF | 1 |
Auerbach, M; Goodnough, LT; Maniatis, A; Picard, D | 1 |
Birgegård, G; Hedenus, M | 1 |
Hung, SC; Kuo, KL; Tarng, DC; Wei, YH | 1 |
Cuenca, J; García-Erce, JA; Muñoz, M | 1 |
Auerbach, M; Ballard, H | 1 |
Kapelushnik, J; Levy, J; Moser, A; Pinsk, V; Yerushalmi, B | 1 |
Kaplinsky, C | 1 |
Anirban, G; Gupta, KL; Jha, V; Kohli, HS; Sakhuja, V | 1 |
Backe, B; Borthen, I; Kolås, T; Løkvik, B; Nakling, J; Rognerud Jensen, OH; Salvesen, KA; Smedvig, E; Westad, S; Økland, I | 1 |
Haraldsson, B; Nilsson, U; Stefánsson, BV | 2 |
Bailey, G; Cropper, L; Mostafa, S; Pugh-Clarke, K; Tagboto, S; Turner, J | 1 |
Arnaout, L; Bellamy, L; Chabbouh, T; Ozier, Y; Rosencher, N | 1 |
Bolaños, L; González-Juanatey, C; Ranero, R; Testa, A | 1 |
Collins, AJ; Foley, RN; Gilbertson, DT; Ibrahim, HN; Zhang, R | 1 |
Abbadi, R; Haddad, A; Marji, A | 1 |
Lorch, JA; Pollak, VE; Satwah, S; Shukla, R | 1 |
Clark, SF | 1 |
Bisbe, E; Campos, A; Díez-Lobo, AI; García-Erce, JA; Muñoz, M; Sebastianes, C | 1 |
Breborowicz, A; Kupczyk, M; Oreopoulos, DG; Połubinska, A; Wanic-Kossowka, M | 1 |
Befrits, R; Blom, H; Eriksson, A; Grännö, C; Hjortswang, H; Lindgren, A; Lindgren, S; Ung, KA; Unge, P; Wikman, O | 1 |
Chung, HH; Kang, SB; Kim, SC; Kim, YH; Kim, YT | 1 |
Gorder, V; Khosla, S; Kuntz, S | 1 |
Bencaiova, G; von Mandach, U; Zimmermann, R | 1 |
Chiu, DY; Fenwick, S; Kalra, PA; Kolakkat, S; Lamerton, E; Peebles, G; Sinha, S | 1 |
Grote, L; Hedner, J; Leissner, L; Ulfberg, J | 1 |
Dejaco, C; Gasche, C; Kulnigg, S; Teischinger, L; Waldhör, T | 1 |
Asma, S; Boga, C; Ozdogu, H | 1 |
Cuenca, J; García-Erce, JA; Haman-Alcober, S; Herrera, A; Martínez, AA; Muñoz, M | 1 |
Nguyen, TV | 1 |
Bencaiova, G; Breymann, C; Krafft, A | 1 |
Angerosa, M; Cao, G; Oliveri, L; Toblli, JE | 4 |
Fujita, T; Fukumoto, S; Ito, N; Okamoto, T; Shimizu, Y; Sugimoto, T; Suzuki, H; Tada, Y; Yamauchi, M | 1 |
Durran, A; Edwards, TJ; Hosie, KB; Mellor, N; Noble, EJ | 1 |
García-Erce, JA; Gómez-Ramírez, S; Muñoz, M | 1 |
Dorrington, KL; León-Velarde, F; Nickol, AH; Privat, C; Ratcliffe, PJ; Rivera-Ch, M; Robbins, PA; Smith, TG; Talbot, NP | 1 |
Bruguera, J; Cladellas, M; Comín-Colet, J; Rizzo, M; Ruiz, S; Torres, A | 1 |
Cooper, B; Healy, H; Irish, AB; Kark, A; Kent, AB; Kerr, PG; McMahon, LP; Roger, SD | 1 |
Bârsan, L; Mircescu, G; Stanciu, A; Stancu, S | 1 |
Dangsuwan, P; Manchana, T | 1 |
Akatsuka, S; Hu, Q; Nagai, H; Ohara, H; Okazaki, Y; Takahashi, T; Toyokuni, S; Yamashita, Y | 1 |
Acheson, AG; Brookes, MJ; Iqbal, T; Simpson, JA; Tselepis, C | 1 |
Pramesh, CS; Ranganathan, P | 1 |
Alonso, E; Canser, E; Gilsanz, F; Gredilla, E; Martínez Serrano, B; Pérez-Ferrer, A | 1 |
Yee, J | 1 |
Chen, HH; Chen, YC; Chuang, CK; Lee, KF; Lin, HC; Wu, CJ | 1 |
Andreoli, MC; Carneiro, FD; Espósito, BP; Guimarães-Souza, NK; Mallet, AC; Matos, AC; Rangel, EB; Santos, BF | 1 |
Tampi, R | 1 |
Bregman, DB; Butcher, A; Goodnough, LT; Harrington, RA; Koch, TA; Morris, D; Onken, JE; Szczech, LA; Wolf, M | 1 |
Coma-Canella, I; Echeverria, A; Garcia-Fernandez, N; Páramo, JA; Sanchez-Ibarrola, A | 1 |
Berman, L; Firoz, BF; Goldberg, LH; Kaye, V; Landau, J | 1 |
Becker, K; Johnson, AC; Zager, RA | 1 |
Fernández-Gallego, J; Martín, MA; Sujan, S; Vega, E | 1 |
Agarwal, SK; Dogra, M; Gupta, A; Khaira, A | 1 |
Bhandari, S; Chinnappa, S | 1 |
Birgegård, G; Schneider, K; Ulfberg, J | 1 |
Hojs, N; Malovrh, M; Premru, V | 1 |
Benítez, PC; Cabello, LM; Chofles, LC; Lázaro, PS; Serrano-Trenas, JA; Ugalde, PF | 1 |
Goldenberg, H; Scheiber-Mojdehkar, B; Steinkellner, H; Sturm, B; Ternes, N | 1 |
Gupta, A; Olp, J; Pai, A; Reddy, S; Zha, J; Zhuo, J | 1 |
Dakshina Murty, KV; Naidu, MU; Neela, P; Ram, R; Swarnalatha, G | 1 |
Froessler, B; Papendorf, D | 1 |
Agarwal, R; Dahl, NV; Leehey, DJ; Olsen, SM | 1 |
Brin, JF; Crommelin, DJ; Klinger, E; Mühlebach, S; Schellekens, H; Storm, G | 1 |
Bager, P; Dahlerup, JF | 1 |
Breymann, C; Krafft, A | 1 |
Kim, S; Lee, SC; Lim, H; Yoon, J | 1 |
Conner, T; Hicks, P; McQuade, CR; Olp, J; Pai, AB | 1 |
Fenwick, S; Peebles, G | 1 |
Auerbach, M | 1 |
Buchanan, GR; Crary, SE; Hall, K | 1 |
Cheng, S; Coppol, E; Kaakeh, Y; Shelly, J; Shepler, B | 1 |
Dansaert, A; Kadri, A; Lafuma, A; Leonard, E; Rottembourg, J | 1 |
Atalay, H; Guney, I; Kaya, E; Solak, Y; Turk, S; Turkmen, K | 1 |
Elford, P; Khov-Tran, VV; Leoni, AL; Meier, T; Pater, C; Schropp, P | 1 |
Fujii, H; Fujimori, A; Fukagawa, M; Goto, S; Hasegawa, H; Komaba, H; Nishi, S; Nishioka, M; Takeda, Y; Umezu, M | 1 |
Acar, K; Atalay, H; Govec, N; Solak, Y; Turk, S | 1 |
Bach, V; Gay-Quéheillard, J; Khorsi-Cauet, H; Villegier, AS; Vu'o'ng Lê, B | 1 |
Bokemeyer, B; Chopey, IV; Evstatiev, R; Gasche, C; Gutzwiller, FS; Iqbal, T; Khalif, IL; Marteau, P; Riopel, L; Stein, J | 1 |
Battegay, E; Breymann, C; Furrer, J; Krayenbuehl, PA; Schulthess, G | 1 |
Bailie, GR; Hörl, WH; Verhoef, JJ | 1 |
Gisbert, JP; Gomollón, F | 1 |
Bisbe, E; Díez-Lobo, AI; García-Erce, JA; Muñoz, M | 1 |
Burrows, DM; Corcoran, HF; Dotzauer, H; Goggin, MM; Gozum, SD; Janis, GC; Lundberg, RA; Nguyen, A; Tann, CM | 1 |
Dorrington, KL; León-Velarde, F; Nickol, AH; Privat, C; Rivera-Ch, M; Robbins, PA; Smith, TG; Talbot, NP | 1 |
Degirmenci, NA; Musmul, A; Ozenc, F; Ozkurt, S; Sahin, G; Temiz, G; Yalcin, AU | 1 |
Bach, V; Gay-Quéheillard, J; Khorsi-Cauet, H; Lê, BV | 1 |
Fujita, T; Fukumoto, S; Kinoshita, Y; Taguchi, M; Wada, Y | 1 |
Chow, KU; Dignass, A; Stein, J | 1 |
Ganji, SH; Kamanna, VS; Norris, K; Shelkovnikov, S; Vaziri, ND | 1 |
Cordero, J; Muñoz, M; Naveira, E; Seara, J | 1 |
Korejo, R; Nasir, A; Yasmin, H | 1 |
Conner, TA; McQuade, C; Olp, J; Pai, AB | 1 |
Gollapudi, S; Hassanzadeh, T; Ichii, H; Masuda, Y; Saffarian, M; Vaziri, ND | 1 |
Christoph, P; Pfenniger, A; Schuller, C; Surbek, D | 1 |
Bosch, MA; Bruguera, J; Cladellas, M; Comín-Colet, J; Farré, N; Gómez, M; Meroño, O; Molera, R; Segovia, A; Vila, J | 1 |
Bhandari, S; Muñoz, M; Reinisch, W; Staun, M | 1 |
Ghosh, P; Kaundal, A; Kochhar, PK | 1 |
Bradbury, BD; Brookhart, MA; Freburger, JK; Kshirsagar, AV; Ng, LJ | 1 |
Ávalos-Pinto, R; de la Llana-Ducrós, R; Garrido-Martín, P; Jimenez-Sosa, A; Martínez-Sanz, R; Nassar-Mansur, MI; Rodríguez Fortunez, PM; Virgos-Aller, TM | 1 |
Christoph, P; De Tejada, BM; Irion, O; Schuller, C; Studer, H; Surbek, D | 1 |
Borchard, G; Flühmann, B; Mühlebach, S | 1 |
Chen, J; Chen, X; Cheng, M; Peng, Y; Yang, L; Yin, L | 1 |
Abel, GA; Hevelone, N; Mandell, E; Okam, MM; Ross, A; Wentz, R | 1 |
Fukumoto, S; Mori, H; Okada, Y; Tanaka, Y; Yamamoto, S | 1 |
Hutchings, A; Jeans, A; Macdougall, IC; Wilson, PD | 1 |
Benmaadi, A; Bounhiol, C; Cohen, Y; Couprie, R; Dahan, H; Drahi, G; Griuncelli, M; Janklewicz, P; Loridon, C; Machado, G; Rostoker, G; Roy, M | 1 |
Cocchiaro, C; Dekker, G; Froessler, B; Hodyl, N; Saadat-Gilani, K | 1 |
Bockeria, LA; Bockeria, O; Donakanian, S; Sokolskaya, M | 1 |
Devasenapathy, N; Neogi, SB; Zodpey, S | 1 |
Goldstein, SL; Morris, D; Warady, BA | 1 |
Albareda Albareda, J; Blanco Rubio, N; Burillo Fuertes, P; Llorens Eizaguerri, M; Ranera García, M; Seral García, B | 1 |
Choi, GY; Kim, JS; Lee, ES; Lee, IS; Lee, JJ; Park, BR | 1 |
Akarsu, S; Demir, H; Oguzoncul, F; Selek, S | 1 |
Kildahl-Andersen, O; Kildahl-Andersen, R; Moore, KL; Tjønnfjord, GE | 1 |
Araki, T; Miyazaki, A; Nakamura, T; Ohshima, S; Shibamiya, T; Takaai, M; Yamamoto, K | 1 |
Amorós-Amorós, F; Enríquez-Ascarza, R; González-Martinez, C; Millán-del Valle, I; Redondo-Pachón, MD; Sirvent-Pedreño, AE | 1 |
Basora, M; Ciercoles, E; Colomina, MJ; Mora, L; Salazar, F; Tio, M | 1 |
Burden, R; Horgan, G; Moore, B; Pedlar, CR; Pollock, N; Whyte, GP | 1 |
Arao, T; Kurozumi, A; Mori, H; Okada, Y; Tanaka, Y; Torimoto, K; Yamamoto, S | 1 |
Lynn, S; McDaniel, J | 1 |
Biggar, P; Hahn, KM | 1 |
Beck-da-Silva, L; Bocchi, E; Clausell, N; de Albuquerque, D; Montera, MW; Moura, LZ; Pereira-Barretto, AC; Piardi, D; Rassi, S; Rohde, LE; Soder, S; Vilas-Boas, F | 1 |
Bailie, GR; Leggett, RE; Levin, R; Li, H; Li, HD; Patadia, H; Schuler, C | 1 |
Barot, BS; Mehta, DM; Parejiya, PB; Shah, GB; Shelat, PK | 1 |
Amet, S; Deray, G; Janus, N; Launay-Vacher, V; Mahi, L; Rey, JB; Rouillon, L; Scotte, F; Zakin, L | 1 |
Münch, HG; Potthoff, SA | 1 |
Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Seidel, L; Servais, S; Vanstraelen, G; Willems, E | 1 |
Barnuevo, MD; Contreras, C; Espadaler, J; Guillén, I; Lázaro, E; López-Román, J; Luque, A; Villegas, JA | 1 |
Bentley, DP; Meek, EM | 1 |
Achermann, R; Giger, M | 1 |
Bregman, DB; Buerkert, J; Butcher, A; Goodnough, LT; Hamerski, D; Harrington, RA; Iftikhar, H; Koch, TA; Mangoo-Karim, R; Martin, ER; Martinez, CO; Morris, D; Newman, GE; Onken, JE; Qunibi, WY; Ross, DL; Singh, B; Smith, MT | 1 |
Grim, K; Kotagal, S; Lee, B; Sung, AY | 1 |
Oertel, WH; Ries, V; Vadasz, D | 1 |
Forward, DP; Moppett, IK; Rowlands, M; Sahota, O | 1 |
Abbasi, S; Abdel-Razeq, H; Abdelelah, H; Jaber, R; Saadi, I | 1 |
Kalaivani, K | 1 |
Agarwal, N; Bhatla, N; Dash, BB; Kriplani, A; Kulshreshta, V; Mahey, R | 1 |
Michigami, T | 1 |
Braunhofer, P; Brock, E; Schneider, H; Troxler, J | 1 |
Akin, M; Atay, E; Erdogan, F; Karadeniz, C; Karakus, YT; Oztekin, O; Yilmaz, B | 1 |
Athibovonsuk, P; Manchana, T; Sirisabya, N | 1 |
Cornelius, C; Goldenberg, H; Praschberger, M; Scheiber-Mojdehkar, B; Schitegg, M; Sturm, B | 1 |
Toyokuni, S | 1 |
Hosoki, T; Ikuta, K; Kanada, H; Kohgo, Y; Moriguchi, Y; Sasaki, K; Sasaki, Y; Shimonaka, Y; Torimoto, Y | 1 |
Colah, R; Ghosh, K; Italia, K | 1 |
Coloma, JL; Esteve, J; Masoller, N; Palacio, M; Perelló, MF | 1 |
Faustino, PJ; Khan, MA; Raw, A; Shah, RB; Yang, Y; Yu, LX | 1 |
Dellanna, F; Hertel, J; Li, Z; Macdougall, IC; McLaughlin, J; Strauss, WE | 1 |
Boland, JP; Kusminsky, RE; Maxwell, D; Richmond, BK; Schlarb, CA; Todd Kuenstner, J; Willis Trammell, S; Witsberger, T | 1 |
Hammami Ghorbel, H; Lacour, JP; Passeron, T | 1 |
Mekic, M; Musanovic, A; Trnacevic, S | 1 |
Allen, LF; Bernard, K; Hetzel, D; Li, Z; Strauss, W; Urboniene, A | 1 |
Hung, SC; Kuo, KL; Lee, TS; Tarng, DC | 1 |
Cava-Sumner, B; Domínguez-Ortega, J; Kindelan-Recarte, C; Montojo-Guillén, C; Nuñez-Acevedo, B; Rodríguez-Jiménez, B | 1 |
Florey, L | 1 |
Berry, S; Burlew, CC; Cappa, A; Holena, DN; Jaouen, B; Jurkovich, J; Maier, R; Moore, EE; Pieracci, FM; Rodil, M; Stovall, RT | 1 |
Baranto, A; Barreto Henriksson, H; Brantsing, C; Junevik, K; Papadimitriou, N; Thorfve, A | 1 |
Angerosa, M; Cao, G; Dominici, FP; Giani, JF; Toblli, JE | 1 |
Artz, AS; Barnhart, H; Berger, NA; Chelune, G; Cohen, HJ; Ershler, WB; Gordeuk, VR; Prchal, J; Price, E; Rao, SV; Reuben, D; Roy, CN; Sapp, S; Schrier, SL; Supiano, MA; Walston, JD | 1 |
Li, J; Mi, C; Shi, Q; Xing, A; Yang, J; Yao, Q | 1 |
Corwin, HL; Napolitano, LM | 1 |
Beguin, Y; Jaspers, A | 1 |
Albinarrate, A; Barrachina, B; López-Ariznabarreta, C; López-Picado, A; Molano, J; Oiartzabal, I | 1 |
Cornelius, C; Goldenberg, H; Haider, K; Praschberger, M; Scheiber-Mojdehkar, B; Schitegg, M; Sturm, B | 1 |
Angerosa, M; Cao, G; Toblli, JE | 1 |
Di Gennaro, F; Rivas, C; Toblli, JE | 1 |
Chatzimichael, A; Mantadakis, E; Tsouvala, E; Xanthopoulou, V | 1 |
Afzal, R; Hanif, MO | 1 |
Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Servais, S; Willems, É | 1 |
Leng, W; Li, J; Mi, C; Shi, Q; Wazir, R; Xing, A; Yang, J; Yao, Q | 1 |
Abdollahi, M; Baeeri, M; Baghaei, A; Golaghaei, A; Hasani, S; Hosseini, R; Navaei, M; Ostad, SN; Solgi, R | 1 |
Ambühl, PM; Bhandari, S; Christensen, JH; Coyne, DW; Essaian, AM; Kalra, PA; Kothari, J; Macdougall, IC; Thomsen, LL | 1 |
Connor, JR; Nixon, AM; Perno, JR; Webb, B; Zhang, X | 1 |
Ang, D; Bavry, AA; Beck, A; Efron, P; Rebel, A | 1 |
Agarwal, R; Kusek, JW; Pappas, MK | 1 |
Bouet, PE; Descamps, P; Gillard, P; Legendre, G; Ruiz, V; Sentilhes, L | 1 |
Fukumoto, S; Takashi, Y | 1 |
Allen, VM; Nash, CM | 1 |
Chen, L; Hong, H; Li, T; Man, C; Ren, X; Wang, H; Ye, P; Zhang, Q | 1 |
Fujii, M; Harada, D; Hashida, S; Hotta, K; Isozaki, H; Kato, Y; Kiura, K; Kubo, T; Kudo, K; Minami, D; Ochi, N; Ohashi, K; Sato, A; Tabata, M; Takigawa, N; Tanaka, T; Tanimoto, M; Toyooka, S | 1 |
Airy, M; Brookhart, MA; Chang, TI; Ding, VY; Goldstein, BA; Mandayam, S; Mitani, AA; Winkelmayer, WC | 1 |
Brookhart, MA; Ellis, AR; Freburger, JK; Kshirsagar, AV; Wang, L; Winkelmayer, WC | 1 |
Han, ZT; Hong, M; Li, H; Zhao, YS | 1 |
Graham, DJ; Houstoun, M; Kane, RC; Kelman, JA; Levenson, M; Limb, S; MaCurdy, TE; Mott, K; Reichman, ME; Ryan, Q; Sheu, TC; Wang, C; Wernecke, M; Wong, S; Worrall, C; Xie, D | 1 |
Couffignal, C; Driss, F; Dufour, G; Duval, X; Lasocki, S; Lefebvre, T; Piednoir, P; Puy, H; Rineau, E; Schilte, C | 1 |
Angmo, S; Mukhija, K; Sandhir, R; Singhal, K; Singhal, NK; Yadav, H; Yadav, K | 1 |
Chakraborty, S; Chaudhuri, MG; Dey, R; Jha, J | 1 |
Clavel, T; Fedorak, R; Haller, D; Lagkouvardos, I; Lee, T; Lucio, M; Michalke, B; Schmidt, A; Schmitt-Kopplin, P; Smirnov, K; Walker, A | 1 |
Bhatla, N; Kachhawa, G; Kriplani, A; Mahey, R; Mogili, KD; Saxena, R | 1 |
Amato, C; Barbieri, C; Bellocchio, F; Bolzoni, E; Canaud, B; Cattinelli, I; Gatti, E; Macdougall, IC; Mari, F; Martin, JD; Stopper, A; Stuard, S | 1 |
Crumbliss, AL; Gupta, A; Pratt, RD | 1 |
Absar, M; Chen, L; Choi, S; Petrochenko, P; Wong, SY; Wu, Y; Zheng, J | 1 |
Han, YM; Im, JP; Jung, HC; Kim, BG; Kim, JS; Koh, SJ; Shin, CM; Yoon, H | 1 |
Cao, G; Dominici, FP; Giani, JF; Rivas, C; Toblli, JE | 1 |
Ferreira, LM; Garcia, EB; Montano-Pedroso, JC; Novo, NF; Veiga, DF | 1 |
Dorsch, MP; Hanigan, S; Kaminsky, BM; Koelling, TM; Pogue, KT | 1 |
Frostad, KB; Johnson, AC; Zager, RA | 1 |
Fell, LH; Fliser, D; Heine, GH; Rotter, B; Seiler-Mußler, S; Sellier, AB; Sester, M; Winter, P; Zawada, AM | 1 |
Cebrián, C; Deira, J; Fernández-Pereira, L; Gómez-Martino, JR; González-Sanchidrián, S; Jiménez, M; Marín, J; Polanco, S; Tabernero, J | 1 |
Macdougall, IC | 1 |
Coyne, DW; Daloul, R; Pandey, R | 1 |
Kozlovskaya, LV; Markina, MM; Milovanov, YS; Milovanova, SY; Mukhin, NA | 1 |
Danko, I; Weidkamp, M | 1 |
Gemici, C; Mayadagli, A; Ozden, S; Ozyurt, H; Tepetam, H; Yaprak, G; Yetmen, O | 1 |
Aleman, T; Bhuyan, RK; Dunaief, JL; Kanu, LN; Kelly, KL; Li, Y; Morgan, JI; Song, D | 1 |
Lopes, AI; Maltez, C; Valério de Azevedo, S | 1 |
Donpunha, W; Kukongviriyapan, U; Kukongviriyapan, V; Pakdeechote, P; Sangartit, W; Shibahara, S | 1 |
Bansal, SS; Huang, L; Kent, AB; Lee, D; Macdougall, IC; MacGinley, R; McMahon, LP; Roberts, MA; Troster, SM | 1 |
Berger, SP; Daha, MR; de Vlaam, TP; Franssen, CF; Gaillard, CA; Gaya da Costa, M; Hempel, JC; Poppelaars, F; Seelen, MA | 1 |
Bugat, R; Duvillié, L; Espié, M; Luporsi, E; Perot, S; Pithois Merli, I; Scotté, F; Spaeth, D; Toledano, A | 1 |
Achebe, MM; Auerbach, M; Derman, R; Modiano, MR; Roman, E; Thomsen, LL | 1 |
Airy, M; Brookhart, MA; Chang, TI; Ding, VY; Fishbane, S; Goldstein, BA; Mandayam, S; Mitani, AA; Winkelmayer, WC | 1 |
Deverdun, J; Le Bars, E; Menjot de Champfleur, N; Molino, F | 1 |
Hamano, H; Hirayama, T; Horinouchi, Y; Ikeda, Y; Ishizawa, K; Izawa-Ishizawa, Y; Kihira, Y; Kishi, S; Miyamoto, L; Nagasawa, H; Oshima, K; Tamaki, T; Tsuchiya, K; Watanabe, H | 1 |
Deng, Y; Jia, Q; Wu, J | 1 |
Frey, M; Kerrey, BT; Overmann, KM; Richert, A | 1 |
Batycky, A; Bernard, K; Dahl, NV; Li, Z; Macdougall, IC; Strauss, WE | 1 |
Bhavi, SB; Jaju, PB | 1 |
Chow, E; Kaneva, K; Kelly, MJ; Rosenfield, CG | 1 |
Delrow, JJ; Johnson, ACM; Zager, RA | 1 |
Barea-Mendoza, J; Brashears, SL; Cortés-Puch, I; Kim-Shapiro, DB; Klein, HG; Natanson, C; Perlegas, A; Solomon, SB; Suffredini, DA; Sun, J; Xu, W | 1 |
Lee, S; Raw, A; Tyner, K; Zou, P | 1 |
Allen, BG; Berg, DJ; Brandt, KE; Buettner, GR; Cullen, JJ; Falls, KC; Fath, MA; Gu, Z; Rodman, SN; Schoenfeld, JD; Spitz, DR; Wagner, BA; Zhan, F | 1 |
Atsumi, T; Kitao, N; Miyoshi, H; Nagai, S; Nakamura, A; Nomoto, H; Shimizu, C | 1 |
Pai, AB | 1 |
Muduma, G; Pollock, RF | 1 |
Altaner, C; Altanerova, U; Altanerova, V; Babincova, M; Babinec, P; Benejova, K; Jakubechova, J; Repiska, V; Zduriencikova, M | 1 |
Imai, N; Shibagaki, Y; Taki, Y | 1 |
Borchard, G; Di Francesco, T; Philipp, E | 1 |
Coll, E; Corredor, ZF; Marcos, R; Pastor, S; Rodríguez-Ribera, L; Stoyanova, E | 1 |
Borchard, G; Di Francesco, T | 1 |
Catarinolo, M; Enzmann, H; Fütterer, S; Langguth, P; Schlösser, C; Schnorr, J; Spicher, K | 1 |
Abergel, A; Aumaitre, O; Bagel, S; Boisgard, S; Delpeuch, A; Ruivard, M; Sautou, V | 1 |
Cunha, GJL; Menezes Falcão, L; Rocha, BML | 1 |
Alcântara Rodrigues de Moraes, M; Bueno Garcia, E; Francescato Veiga, D; Masako Ferreira, L; Montano-Pedroso, JC | 1 |
Bai, Z; Feng, R; Guo, X; Hong, C; Qi, X; Romeiro, FG; Xu, X; Zhang, D | 1 |
Walther, CP; Winkelmayer, WC; Yan, J | 1 |
Butragueño-Laiseca, L; de la Mata Navazo, S; Sánchez Galindo, AC; Santiago Lozano, MJ | 1 |
39 review(s) available for glucaric acid and ferric oxide, saccharated
Article | Year |
---|---|
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
Safety aspects of parenteral iron in patients with end-stage renal disease.
Topics: Anemia, Iron-Deficiency; Citric Acid; Drug Combinations; Drug Monitoring; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Compounds; Iron Overload; Iron-Dextran Complex; Kidney Failure, Chronic; Sorbitol | 1997 |
Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy.
Topics: Aged; Anemia, Iron-Deficiency; Anemia, Refractory; Animals; Calcitriol; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Iatrogenic Disease; Kidney Diseases; Male; Middle Aged; Osteomalacia; Phosphates | 1998 |
[Iron supplementation in preterm infants treated with erythropoietin].
Topics: Adult; Dietary Supplements; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Kidney Failure, Chronic; Recombinant Proteins | 1999 |
Parenteral iron use in the management of anemia in end-stage renal disease patients.
Topics: Anemia, Iron-Deficiency; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Peritoneal Dialysis; Recombinant Proteins; Renal Dialysis | 2000 |
Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Parenteral; Pregnancy; Pregnancy Complications, Hematologic | 2002 |
Iron sucrose: the oldest iron therapy becomes new.
Topics: Chronic Disease; Drug Administration Schedule; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Diseases; Treatment Outcome | 2002 |
Clinical review of the newer intravenous iron therapy options.
Topics: Anemia, Iron-Deficiency; Clinical Protocols; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Renal Dialysis; Transferrin; Treatment Outcome | 2003 |
[Indications and practical management of parenteral iron therapy].
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Child; Erythrocyte Count; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Male; Renal Dialysis; Sucrose; Time Factors; Transferrin | 2003 |
Parenteral iron therapy options.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex | 2004 |
Intravenous iron therapy: well-tolerated, yet not harmless.
Topics: Anemia; Cytokines; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Hematinics; Humans; Injections, Intravenous; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Neutrophils | 2005 |
Acute injury with intravenous iron and concerns regarding long-term safety.
Topics: Acute Kidney Injury; Anemia, Iron-Deficiency; Animals; Atherosclerosis; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation; Infusions, Intravenous; Iron-Dextran Complex; Oxidative Stress; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Transferrin | 2006 |
Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Anemia, Iron-Deficiency; Animals; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Cortex; Kidney Tubules, Proximal; Lipid Peroxidation; Mitochondria; Oxidative Stress; Renal Dialysis; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha | 2006 |
[Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease].
Topics: Administration, Oral; Anemia, Iron-Deficiency; Diet, Protein-Restricted; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron Metabolism Disorders; Iron, Dietary; Kidney Failure, Chronic; Risk Factors; Sex Distribution; Treatment Outcome | 2007 |
[Drug-induced osteomalacia].
Topics: Anticonvulsants; Etidronic Acid; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Osteomalacia | 2007 |
Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease.
Topics: Chronic Disease; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Iron-Dextran Complex; Kidney Diseases | 2008 |
The role of intravenous iron in anemia management and transfusion avoidance.
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Erythropoiesis; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous | 2008 |
The role of iron supplementation during epoietin treatment for cancer-related anemia.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Drug Administration Schedule; Erythropoiesis; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Iron, Dietary; Maltose; Neoplasms; Randomized Controlled Trials as Topic | 2009 |
Intravenous iron in oncology.
Topics: Anemia; Antineoplastic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex; Neoplasms | 2008 |
[Blood conservation approaches in orthopedic surgery].
Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemodilution; Humans; Intraoperative Complications; Orthopedic Procedures; Postoperative Hemorrhage; Preoperative Care; Recombinant Proteins; Sucrose; Time Factors; Tranexamic Acid; Transfusion Reaction | 2008 |
Iron deficiency anemia: diagnosis and management.
Topics: Anemia, Iron-Deficiency; Antimicrobial Cationic Peptides; Biomarkers; Endoscopy, Digestive System; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hepcidins; Humans; Infusions, Parenteral; Iron; Iron Chelating Agents | 2009 |
Intravenous iron in inflammatory bowel disease.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Injections, Intraventricular; Iron; Iron-Dextran Complex; Maltose; Treatment Outcome | 2009 |
A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Clinical Trials as Topic; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Ferrous Compounds; Glucaric Acid; Humans; Iron-Dextran Complex; Renal Dialysis; Renal Insufficiency, Chronic | 2011 |
State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease.
Topics: Algorithms; Anemia, Iron-Deficiency; Clinical Trials as Topic; Diagnosis, Differential; Disaccharides; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron Deficiencies; Maltose; Prevalence; Thrombocytosis; Thromboembolism | 2013 |
Is intravenous iron sucrose the treatment of choice for pregnant anemic women?
Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome | 2013 |
[Importance of the different i.v. iron generations for everyday medical practice].
Topics: Anemia, Iron-Deficiency; Disaccharides; Dose-Response Relationship, Drug; Drug Substitution; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Maltose; Structure-Activity Relationship; Treatment Outcome | 2013 |
[Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].
Topics: Administration, Oral; Anaphylaxis; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Oxidative Stress; Renal Dialysis | 2013 |
[Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia].
Topics: Diagnosis, Differential; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Humans; Osteomalacia; Phosphates; Rickets, Hypophosphatemic | 2013 |
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis.
Topics: Adsorption; Animals; Asbestos; Asbestosis; Benzoates; Carcinogens, Environmental; Carcinoma, Renal Cell; Cell Transformation, Neoplastic; Comparative Genomic Hybridization; Deferasirox; Ferric Compounds; Ferric Oxide, Saccharated; Genes, p16; Glucaric Acid; Humans; Iron Chelating Agents; Iron Overload; Japan; Kidney Neoplasms; Male; Mesothelioma; Mineral Fibers; Peritoneal Neoplasms; Phlebotomy; Pleural Neoplasms; Rats; Triazoles | 2014 |
Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Birth Weight; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Iron; Pregnancy; Pregnancy Complications, Hematologic; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas.
Topics: Anemia, Iron-Deficiency; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron Deficiencies | 2014 |
Intravenous Iron Sucrose versus Oral Iron in the Treatment of Pregnancy with Iron Deficiency Anaemia: A Systematic Review.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Iron Compounds; Pregnancy; Pregnancy Complications, Hematologic | 2015 |
[Bone and Nutrition. The relationship between iron and phosphate metabolism].
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Humans; Hypophosphatemia; Injections, Intravenous; Iron; Osteomalacia; Phosphates; Renal Insufficiency, Chronic; Rickets, Hypophosphatemic | 2015 |
The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Iron-Dextran Complex; Puerperal Disorders | 2015 |
Iron Treatment Strategies in Nondialysis CKD.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Maltose; Renal Insufficiency, Chronic; Severity of Illness Index; Transferrin | 2016 |
Iron Treatment Strategies in Dialysis-Dependent CKD.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Renal Dialysis; Transferrin | 2016 |
Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.
Topics: Colloids; Drug Discovery; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron-Dextran Complex; Molecular Weight; Particle Size | 2017 |
Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron; Nanoparticles; Therapeutic Equivalency; Treatment Outcome | 2017 |
Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.
Topics: Acute Disease; Anemia, Iron-Deficiency; Chronic Disease; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Hospitalization; Humans; Quality of Life; Renal Insufficiency, Chronic | 2018 |
140 trial(s) available for glucaric acid and ferric oxide, saccharated
Article | Year |
---|---|
Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery.
Topics: Administration, Oral; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Prosthesis; Humans; Injections, Intravenous; Premedication; Recombinant Proteins; Safety; Treatment Outcome | 1996 |
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery.
Topics: Anemia; Blood Transfusion; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Male; Orthopedics; Premedication; Recombinant Proteins; Reticulocyte Count; Sex Characteristics; Treatment Outcome | 1996 |
A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
Topics: Administration, Oral; Anemia, Neonatal; Blood Cell Count; Blood Transfusion; Erythrocyte Count; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematocrit; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Injections, Intravenous; Iron; Lactates; Male; Recombinant Proteins; Reticulocytes | 1996 |
Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers.
Topics: Adult; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Half-Life; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Receptors, Transferrin; Spectrophotometry, Atomic; Sucrose; Transferrin | 1996 |
Intravenous ferric saccharate as an iron supplement in dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Combinations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Renal Dialysis | 1996 |
Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Reference Values; Sucrose; Time Factors | 1996 |
Safety of intravenous injection of iron saccharate in haemodialysis patients.
Topics: Adult; Aged; Drug Tolerance; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Transferrin | 1996 |
The efficiency of fractionated parenteral iron treatment in CAPD patients.
Topics: Adult; Anemia; Drug Administration Schedule; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Organization and Administration; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Sucrose; Transferrin | 1997 |
Iron supplementation in haemodialysis--practical clinical guidelines.
Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Administration Routes; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Iron; Iron Deficiencies; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Support; Practice Guidelines as Topic; Prospective Studies; Recombinant Proteins; Renal Dialysis; Sucrose; Transferrin | 1998 |
Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study.
Topics: Administration, Oral; Adult; Blood Donors; Blood Transfusion, Autologous; Elective Surgical Procedures; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematologic Tests; Humans; Injections, Intravenous; Male; Postoperative Care; Preoperative Care; Treatment Outcome | 1999 |
Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.
Topics: Adult; Anemia, Iron-Deficiency; C-Reactive Protein; Colitis, Ulcerative; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Glucocorticoids; Hemoglobins; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Recombinant Proteins; Reticulocyte Count; Treatment Outcome | 1999 |
Erythropoietic quality of maternal milk.
Topics: Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Infant, Premature; Milk, Human; Recombinant Proteins | 1999 |
Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial.
Topics: Anemia, Iron-Deficiency; Blood Pressure; Drug Hypersensitivity; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2000 |
Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration.
Topics: Adult; Aged; Bleomycin; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Staphylococcus epidermidis; Transferrin | 2000 |
Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy.
Topics: Anemia; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Middle Aged; Recombinant Proteins; Renal Dialysis; Uremia | 2000 |
Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Topics: Administration, Oral; Ascorbic Acid; Blood Cell Count; Drug Therapy, Combination; Erythrocyte Indices; Erythrocyte Transfusion; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Injections, Intravenous; Iron; Malondialdehyde; Prospective Studies; Tyrosine | 2001 |
Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
Topics: Aged; Anemia, Iron-Deficiency; Epoetin Alfa; Erythrocyte Indices; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2001 |
Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy.
Topics: Anemia, Iron-Deficiency; Erythrocyte Count; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fetal Growth Retardation; Glucaric Acid; Hematocrit; Humans; Placental Insufficiency; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Recombinant Proteins; Reticulocyte Count; Transferrin; Treatment Outcome; Ultrasonography | 2001 |
The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Sucrose | 2001 |
A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.
Topics: Administration, Oral; Aged; Disease Progression; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Gastrointestinal Diseases; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency | 2001 |
A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.
Topics: Drug Administration Schedule; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Recombinant Proteins; Renal Dialysis; Sucrose; Time Factors; Transferrin | 2001 |
Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
Topics: Anemia, Iron-Deficiency; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Interleukin-6; Logistic Models; Male; Prospective Studies; Receptors, Transferrin; ROC Curve; Sensitivity and Specificity; Transferrin; Treatment Outcome | 2001 |
Intravenous iron sucrose: establishing a safe dose.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Back Pain; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Hypotension; Infusions, Intravenous; Kidney Transplantation; Male; Middle Aged; Nausea; Peritoneal Dialysis; Prospective Studies; Renal Dialysis; Renal Insufficiency; Vomiting | 2001 |
Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
Topics: Adult; Aged; Anemia; Arthritis, Rheumatoid; Disability Evaluation; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Health Status; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Quality of Life; Recombinant Proteins; Severity of Illness Index; Treatment Outcome | 2001 |
Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo.
Topics: Adult; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Male; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Smoking; Vasodilation | 2002 |
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
Topics: Anemia; Dialysis Solutions; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Male; Protein Binding; Renal Dialysis; Transferrin | 2002 |
Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Birth Weight; Delivery, Obstetric; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infant, Newborn; Injections, Intravenous; Iron; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Sulfates | 2002 |
Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
Topics: Aged; Anemia; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2002 |
Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
Topics: Anemia, Iron-Deficiency; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Population Surveillance; Treatment Outcome | 2003 |
The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Topics: Adult; Dose-Response Relationship, Drug; Erythrocyte Deformability; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Sucrose; Time Factors | 2003 |
Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
Topics: Age Factors; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Renal Insufficiency; Severity of Illness Index; Time Factors | 2003 |
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity.
Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Neutrophils; Peritoneal Dialysis; Phagocytosis; Prospective Studies; Respiratory Burst | 2003 |
The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease.
Topics: Aged; Anemia; Blood Pressure; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Transferrin; Treatment Outcome | 2003 |
Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients.
Topics: Adult; Autoimmune Diseases; Bleomycin; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Parenteral; Iron; Iron Deficiencies; Middle Aged; Plasmapheresis; Serum Albumin; Transferrin | 2004 |
A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding.
Topics: Adult; Aged; Aged, 80 and over; Anaphylaxis; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Tolerance; Edema; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Hemorrhage; Glucaric Acid; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Thrombophlebitis; Treatment Outcome; Urticaria | 2004 |
Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sepsis | 2004 |
Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients.
Topics: Antioxidants; Cross-Over Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis; Thiobarbituric Acid Reactive Substances | 2004 |
Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study.
Topics: Aged; Cross Infection; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Fractures; Humans; Infusions, Intravenous; Iron; Length of Stay; Male; Orthopedic Procedures; Pilot Projects; Postoperative Complications; Preoperative Care | 2004 |
On the nature of proteinuria with acute renal injury in patients with chronic kidney disease.
Topics: Aged; Albuminuria; Chronic Disease; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Immunoassay; Infusions, Intravenous; Kidney; Kidney Diseases; Kinetics; Male; Oxidation-Reduction; Oxidative Stress; Proteinuria; Sensitivity and Specificity; Serum Albumin | 2005 |
Endothelial injury markers with high-dose intravenous iron therapy in renal failure.
Topics: Adult; Aged; Biomarkers; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hepatocyte Growth Factor; Humans; Infusions, Intravenous; Iron; Male; Middle Aged; Renal Insufficiency; Thrombomodulin; Thrombosis; von Willebrand Factor | 2004 |
Parenteral iron therapy in treatment of anemia in end-stage renal disease patients: a comparative study between iron saccharate and gluconate.
Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Humans; Kidney Failure, Chronic; Male; Parenteral Nutrition; Renal Dialysis | 2005 |
[Post-haemodilution anaemia in paediatric cardiac surgery: benefit of intravenous iron therapy].
Topics: Anemia; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemodilution; Hemoglobins; Humans; Infant; Infusions, Intravenous; Male; Postoperative Complications; Reticulocyte Count; Sucrose | 2005 |
Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections.
Topics: Adult; Aged; Anaphylaxis; Anemia, Hypochromic; Chronic Disease; Cohort Studies; Dysgeusia; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Graft Rejection; Humans; Hypotension; Injections, Intravenous; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies | 2005 |
Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
Topics: Administration, Oral; Adolescent; Adult; Antioxidants; Biomarkers; C-Reactive Protein; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Crohn Disease; Cross-Over Studies; Feces; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Follow-Up Studies; Glucaric Acid; Humans; Injections, Intravenous; Leukocyte L1 Antigen Complex; Male; Malondialdehyde; Middle Aged; Severity of Illness Index; Treatment Outcome | 2005 |
Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Middle Aged; Nausea; Prospective Studies; Transferrin; Treatment Outcome | 2005 |
Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients.
Topics: Adult; Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Forearm; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Prospective Studies; Regional Blood Flow; Vasodilation | 2005 |
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.
Topics: Administration, Oral; Aged; Anemia; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Patient Compliance; Quality of Life; Renal Insufficiency, Chronic; Treatment Outcome | 2005 |
Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia.
Topics: Analysis of Variance; Anemia; Cardiac Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Orthopedic Procedures; Postoperative Care; Recombinant Proteins; Time Factors; Treatment Outcome | 2006 |
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
Topics: Adult; Anemia, Iron-Deficiency; Brachial Artery; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Homocysteine; Humans; Iron; Male; Methionine; Nitroglycerin; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Transferrin; Tyrosine; Vasodilation | 2006 |
Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Parenteral; Male; Pilot Projects; Retrospective Studies | 2006 |
[Postpartum and early postoperative anemia after gynecological surgery: treatment with intravenous iron].
Topics: Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecologic Surgical Procedures; Humans; Injections, Intravenous; Prospective Studies; Puerperal Disorders; Sucrose | 2006 |
Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients.
Topics: Aged; CD11b Antigen; Female; Ferric Compounds; Ferric Oxide, Saccharated; Flow Cytometry; Glucaric Acid; Granulocytes; Hematinics; Humans; Leukocyte Common Antigens; Leukocytes; Lipopolysaccharide Receptors; Luminescence; Male; Middle Aged; Monocytes; Reactive Oxygen Species; Renal Dialysis; Renal Insufficiency | 2006 |
Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose.
Topics: Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Middle Aged; Protein Binding; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Transferrin | 2006 |
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients.
Topics: Adolescent; Adult; Aged; Darbepoetin alfa; Dose-Response Relationship, Drug; Drug Administration Schedule; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis; Transferrin; Treatment Outcome | 2006 |
Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
Topics: Aged; Anemia; Cardiac Output, Low; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Diseases; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Physical Endurance; Prospective Studies; Transferrin; Walking | 2006 |
Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery.
Topics: Aged; Anemia; Arthroplasty, Replacement, Knee; Blood Component Transfusion; Blood Loss, Surgical; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Perioperative Care; Postoperative Hemorrhage; Receptors, Transferrin; Recombinant Proteins; Reticulocyte Count; Treatment Outcome | 2006 |
Intravenous versus oral iron therapy for postpartum anaemia.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Prospective Studies; Puerperal Disorders | 2006 |
The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C.
Topics: Administration, Oral; Aged; Antioxidants; Ascorbic Acid; Ascorbic Acid Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Thiobarbituric Acid Reactive Substances | 2006 |
Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Middle Aged; Prospective Studies; Uterine Cervical Neoplasms | 2007 |
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Topics: Biomarkers; Cross-Over Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Prospective Studies; Renal Dialysis | 2007 |
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Topics: Aged; Anemia; Antibodies; Aryldialkylphosphatase; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis; Treatment Outcome | 2007 |
Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.
Topics: Adult; Anemia, Iron-Deficiency; Double-Blind Method; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Prospective Studies; Research Design | 2007 |
Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
Topics: Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intra-Arterial; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Middle Aged | 2007 |
[Intravenous treatment of postpartum anemia with trivalent ferrum preparation].
Topics: Anemia, Iron-Deficiency; Blood Cell Count; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Pregnancy; Puerperal Disorders; Sucrose | 2007 |
Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease.
Topics: Aged; Cross-Over Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Treatment Outcome | 2007 |
Optimum dosage regimen for iron sucrose.
Topics: Adult; Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome | 2007 |
Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial.
Topics: Anemia, Iron-Deficiency; Darbepoetin alfa; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Peritoneal Dialysis; Recombinant Proteins | 2006 |
Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation Mediators; Infusions, Intravenous; Interleukin-6; Iron-Dextran Complex; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Serum Albumin; Tumor Necrosis Factor-alpha | 2007 |
Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Double-Blind Method; Exercise Tolerance; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Hematinics; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Quality of Life; Renal Insufficiency, Chronic; Treatment Outcome | 2007 |
Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study.
Topics: Breath Tests; Cytochrome P-450 Enzyme System; Erythromycin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Deficiencies; Liver; Male; Middle Aged; Prospective Studies; Renal Dialysis; Sucrose | 2007 |
Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Topics: Adult; Aged; Anemia; China; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Treatment Outcome | 2008 |
A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Male; Middle Aged; Restless Legs Syndrome; Substantia Nigra; Treatment Failure | 2009 |
Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Antioxidants; Deoxyguanosine; DNA Damage; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Lymphocytes; Middle Aged; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Renal Dialysis | 2008 |
The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
Topics: Adult; Age Factors; Analysis of Variance; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Probability; Renal Dialysis; Risk Assessment; Severity of Illness Index; Sex Factors; Treatment Outcome | 2008 |
A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Postpartum Period; Prospective Studies; Quality of Life; Sucrose | 2008 |
Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Administration Schedule; Drug Monitoring; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glomerular Filtration Rate; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Severity of Illness Index; Sucrose; Transferrin; Treatment Outcome | 2008 |
Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.
Topics: Administration, Oral; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Sweden; Treatment Outcome | 2009 |
Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
Topics: Administration, Oral; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Menorrhagia; Middle Aged; Preoperative Care; Prospective Studies | 2009 |
Iron prophylaxis in pregnancy: intravenous route versus oral route.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Trace Elements; Young Adult | 2009 |
A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome.
Topics: Adult; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Male; Middle Aged; Restless Legs Syndrome; Surveys and Questionnaires; Time Factors | 2009 |
Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.
Topics: Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Iron; Male; Prognosis; Prospective Studies; Recurrence; Treatment Outcome | 2009 |
Safety, therapeutic effectiveness, and cost of parenteral iron therapy.
Topics: Adult; Anemia, Iron-Deficiency; Costs and Cost Analysis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Male; Middle Aged | 2009 |
Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Blood Loss, Surgical; Blood Transfusion; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Folic Acid; Fracture Fixation, Internal; Glucaric Acid; Guideline Adherence; Hip Fractures; Hospitals, University; Humans; Male; Postoperative Complications; Premedication; Prospective Studies; Recombinant Proteins; Retrospective Studies; Vitamin B 12 | 2009 |
Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
Topics: Adult; Anemia; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Pregnancy; Recombinant Proteins; Treatment Outcome | 2009 |
[Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2009 |
Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery.
Topics: Adult; Aged; Anemia, Iron-Deficiency; Blood Transfusion; Colorectal Neoplasms; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Transferrin; Treatment Outcome; Young Adult | 2009 |
Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials.
Topics: Adult; Altitude; Altitude Sickness; Blood Pressure; Cross-Over Studies; Double-Blind Method; Echocardiography, Doppler; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypertension, Pulmonary; Hypoxia; Iron Deficiencies; Male; Middle Aged; Phlebotomy; Pulmonary Artery; Systole; Young Adult | 2009 |
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
Topics: Administration, Oral; Aged; Anemia; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Severity of Illness Index | 2010 |
Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Endometrial Neoplasms; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Paclitaxel; Taxoids; Young Adult | 2010 |
Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients.
Topics: Anemia; Chlorides; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2010 |
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Cardiovascular Diseases; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hemoglobins; Humans; Kidney Diseases; Male; Maltose; Middle Aged; Risk Factors; Sucrose; Treatment Outcome | 2010 |
Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis.
Topics: Acetylcysteine; Aged; Antioxidants; Biomarkers; CD11b Antigen; CD18 Antigens; Cross-Over Studies; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammation; Inflammation Mediators; Infusions, Intravenous; Intercellular Adhesion Molecule-1; Interleukin-8; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome; von Willebrand Factor | 2010 |
High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron.
Topics: Adult; Age Factors; Blood Donors; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Incidence; Iron; Iron Deficiencies; Male; Middle Aged; Restless Legs Syndrome; Sex Factors | 2010 |
Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anemia; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Fractures; Humans; Infusions, Intraventricular; Male; Perioperative Period; Postoperative Complications | 2011 |
Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Topics: Acetylcysteine; Adult; Anemia, Iron-Deficiency; Antioxidants; Biomarkers; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; India; Infusions, Intravenous; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Placebo Effect; Plethysmography; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2010 |
Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial.
Topics: Adult; Aged; Albuminuria; Anemia, Iron-Deficiency; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Creatinine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Diseases; Male; Middle Aged; Proteinuria | 2011 |
Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Topics: Anemia; Anemia, Iron-Deficiency; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Interleukin-6; Pregnancy; Pregnancy Complications; Prospective Studies; Recombinant Proteins; Treatment Outcome | 2011 |
Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
Topics: Adult; Cross-Over Studies; Cytokines; F2-Isoprostanes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Iron-Dextran Complex; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Middle Aged; Molecular Weight; Prospective Studies; Reactive Oxygen Species; Renal Dialysis | 2011 |
Do two intravenous iron sucrose preparations have the same efficacy?
Topics: Anemia, Iron-Deficiency; Cohort Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Prognosis; Renal Dialysis | 2011 |
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Comorbidity; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Maltose; Middle Aged; Outcome Assessment, Health Care; Treatment Outcome; Young Adult | 2011 |
Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration.
Topics: Adult; Double-Blind Method; Fatigue; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Patient Selection; Placebos; Premenopause; Research Design; Sucrose | 2011 |
Intravenous iron supplementation may protect against acute mountain sickness: a randomized, double-blinded, placebo-controlled trial.
Topics: Acute Disease; Adult; Altitude Sickness; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Male; Oxygen; Severity of Illness Index; Sucrose; Young Adult | 2011 |
Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Postoperative Care | 2012 |
Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.
Topics: Adult; Ascorbic Acid; Cross-Over Studies; Cytokines; Epoetin Alfa; Erythropoietin; F2-Isoprostanes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Middle Aged; Oxidative Stress; Prospective Studies; Reactive Oxygen Species; Recombinant Proteins; Systems Biology | 2012 |
Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
Topics: Adult; Anemia, Iron-Deficiency; Dietary Supplements; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; India; Infusions, Intravenous; Iron, Dietary; Pregnancy; Pregnancy Complications; Young Adult | 2013 |
The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial.
Topics: Administration, Oral; Aged; Analysis of Variance; Anemia, Iron-Deficiency; Blood Transfusion; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chi-Square Distribution; Double-Blind Method; Elective Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Spain; Sucrose; Tablets; Time Factors; Treatment Failure | 2012 |
[Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Sucrose; Young Adult | 2012 |
Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Biomarkers; Cross-Sectional Studies; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemosiderosis; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Liver; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2012 |
Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Blood Loss, Surgical; Cesarean Section; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, Third; Young Adult | 2013 |
Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Peritoneal Dialysis; Prospective Studies; Renal Insufficiency, Chronic; Young Adult | 2013 |
Iron deficiency anemia and levels of oxidative stress induced by treatment modality.
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Antioxidants; Child; Child, Preschool; Developing Countries; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Glycine; Hemoglobinometry; Humans; Infant; Infusions, Intravenous; Injections, Intramuscular; Male; Oxidative Stress; Sucrose; Turkey | 2013 |
IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.
Topics: Aged; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2013 |
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial.
Topics: Aged; Anemia; Blood Transfusion; Combined Modality Therapy; Darbepoetin alfa; Drug Therapy, Combination; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lymphoma; Male; Middle Aged; Multiple Myeloma; Postoperative Complications; Quality of Life; Transferrin; Transplantation Conditioning; Transplantation, Autologous | 2013 |
Comparative study of the oral absorption of microencapsulated ferric saccharate and ferrous sulfate in humans.
Topics: Absorption; Adult; Animals; Body Mass Index; Cross-Over Studies; Double-Blind Method; Drug Compounding; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Food, Fortified; Glucaric Acid; Humans; Iron; Male; Milk; Mouth; Postprandial Period | 2014 |
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
Topics: Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron; Male; Maltose; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2014 |
The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial.
Topics: Aged; Anemia; Biomarkers; Clinical Protocols; Drug Administration Schedule; England; Erythrocyte Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Fracture Fixation; Glucaric Acid; Hematinics; Hemoglobins; Hip Fractures; Hospitals, University; Humans; Infusions, Intravenous; Pilot Projects; Postoperative Hemorrhage; Research Design; Reticulocyte Count; Time Factors; Treatment Outcome | 2013 |
Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia.
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Drug Resistance; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Male; Sucrose; Treatment Outcome | 2014 |
Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Genital Neoplasms, Female; Glucaric Acid; Hematinics; Hemoglobins; Humans; Middle Aged; Paclitaxel | 2013 |
Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Infusions, Intravenous; Iron, Dietary; Puerperal Disorders; Severity of Illness Index; Spain; Treatment Outcome | 2014 |
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
Topics: Aged; Anemia, Iron-Deficiency; Biomarkers; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Injections, Intravenous; Least-Squares Analysis; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2014 |
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Humans; Injections, Intravenous; Male; Middle Aged | 2014 |
A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; APACHE; Critical Illness; Erythrocyte Transfusion; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male; Middle Aged; Protoporphyrins; Single-Blind Method; Transferrin; Trauma Centers; Young Adult | 2014 |
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL.
Topics: Aged; Aged, 80 and over; Anemia; Cognition; Drug Administration Schedule; Exercise Test; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Male; Psychological Tests; Quality of Life; Walking | 2014 |
Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Iron; Iron Deficiencies; Male; Pilot Projects; Renal Insufficiency, Chronic; Ventricular Function, Left | 2015 |
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
Topics: Anemia; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Sucrose; Survival Analysis; Transplantation, Autologous | 2015 |
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Disaccharides; Early Intervention, Educational; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Maintenance Chemotherapy; Male; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Young Adult | 2015 |
A randomized trial of intravenous and oral iron in chronic kidney disease.
Topics: Administration, Intravenous; Administration, Oral; Aged; Anemia, Iron-Deficiency; Biomarkers; Disease Progression; Early Termination of Clinical Trials; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glomerular Filtration Rate; Glucaric Acid; Hematinics; Hemoglobins; Humans; Indiana; Kidney; Male; Middle Aged; Quality of Life; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2015 |
Policy of high-dose tranexamic acid for treating postpartum hemorrhage after vaginal delivery.
Topics: Adult; Antifibrinolytic Agents; Female; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Hematinics; Humans; Postpartum Hemorrhage; Pregnancy; Prevalence; Thromboembolism; Tranexamic Acid; Treatment Outcome; Young Adult | 2016 |
Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study.
Topics: Adult; Altitude Sickness; Dietary Supplements; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies | 2015 |
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Colitis, Ulcerative; Crohn Disease; Feces; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Gastrointestinal Microbiome; Glucaric Acid; Hematinics; Humans; Iron Deficiencies; Metabolome; Quality of Life; RNA, Ribosomal, 16S | 2017 |
Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; India; Maltose; Middle Aged; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2016 |
Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial.
Topics: Abdominoplasty; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Anemia; Bariatric Surgery; Biomarkers; Brazil; Clinical Protocols; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hematopoiesis; Hemoglobins; Humans; Middle Aged; Quality of Life; Research Design; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2016 |
Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Hepcidins; Humans; Kidney Failure, Chronic; Maintenance Chemotherapy; Male; Renal Dialysis; Reticulocyte Count; Reticulocytes; Transferrin | 2016 |
Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial.
Topics: Administration, Intravenous; Aged; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Male; Maltose; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic | 2016 |
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Disaccharides; Drug Dosage Calculations; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2017 |
Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
Topics: Administration, Intravenous; Aged; Double-Blind Method; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Iron; Male; Middle Aged; Quality of Life; Renal Dialysis; Restless Legs Syndrome | 2017 |
The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Heart; Hematinics; Humans; Kidney Failure, Chronic; Liver; Magnetic Resonance Imaging; Pancreas; Renal Dialysis | 2017 |
Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Pregnancy; Pregnancy Complications; Prospective Studies; Treatment Outcome | 2017 |
Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil.
Topics: Abdominoplasty; Administration, Intravenous; Administration, Oral; Adult; Anemia; Bariatric Surgery; Biomarkers; Brazil; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Middle Aged; Risk Factors; Treatment Outcome; Young Adult | 2018 |
312 other study(ies) available for glucaric acid and ferric oxide, saccharated
Article | Year |
---|---|
Oral iron therapy with ferrous fumarate and polysaccharide iron complex.
Topics: Administration, Oral; Anemia; Contraindications; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Kidney Diseases; Renal Dialysis | 1992 |
Lipid peroxidation induced "in vivo" by iron-carbohydrate complex in the rat brain cortex.
Topics: Animals; Cerebral Cortex; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Lipid Peroxidation; Male; Methylprednisolone; Penicillamine; Rats; Rats, Inbred Strains; Spectrometry, Fluorescence; Thiobarbiturates; Vitamin E | 1991 |
[Chronic hemorrhagic iron deficiency. Sources of hemorrhage, blood loss and systematic iron substitution].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hypochromic; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemorrhage; Humans; Iron-Dextran Complex; Male; Middle Aged | 1987 |
Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysis.
Topics: Adolescent; Adult; Aged; Alleles; Anemia; Child; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemochromatosis; Humans; Male; Renal Dialysis; Risk; Transfusion Reaction; Uremia | 1987 |
Effects of intravenous administration of iron preparations on the metabolism of phosphorus. Comparative study on 3 iron preparations.
Topics: Adult; Aged; Anemia, Hypochromic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Tubules; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 1984 |
Different actions of deferoxamine and iron on Ga-67 abscess detection in rats.
Topics: Abscess; Animals; Deferoxamine; Drug Evaluation, Preclinical; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gallium Radioisotopes; Glucaric Acid; Iron; Radionuclide Imaging; Rats; Rats, Inbred Strains; Time Factors; Tissue Distribution | 1984 |
[Relative Ga-67 image enhancement by iron-loading].
Topics: Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Squamous Cell; Ferric Compounds; Ferric Oxide, Saccharated; Gallium Radioisotopes; Glucaric Acid; Humans; Image Enhancement; Iron; Lung Neoplasms; Mice; Neoplasms, Experimental; Rabbits; Radionuclide Imaging; Tissue Distribution | 1984 |
[A growth media of genus Legionella in containing saccharated ferric oxide (Fesin) replacing soluble ferric pyrophosphate (author's transl)].
Topics: Anemia; Culture Media; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Legionella | 1982 |
Hypophosphatemia induced by intravenous administration of Saccharated iron oxide.
Topics: Anemia, Hypochromic; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Parenteral; Intestinal Absorption; Iron; Kidney; Phosphates | 1983 |
Enhancing effect of saccharated ferric oxide on human lymphocyte transformation in serum-free medium.
Topics: Cells, Cultured; DNA Replication; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Lymphocyte Activation | 1982 |
[2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide].
Topics: Adult; Anemia, Hypochromic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Intestinal Diseases; Intestine, Small; Iron; Middle Aged; Osteomalacia; Ulcer | 1982 |
[Response of omental milk spots to colloidal saccharated ferric oxide in the mouse: light and electron microscopic study (author's transl)].
Topics: Adipose Tissue; Animals; Colloids; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Lymphoid Tissue; Macrophages; Male; Mice; Omentum; Time Factors | 1981 |
[Protective effect of the lysosomotrophic preparation rheopolyglucin in treating iron-deficient anemia with iron saccharate].
Topics: Anemia, Iron-Deficiency; Animals; Dextrans; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Intracellular Membranes; Kupffer Cells; Lysosomes; Microscopy, Electron; Rabbits | 1994 |
Biological markers of oxidative stress induced by ethanol and iron overload in rat.
Topics: Animals; Biomarkers; Ethanol; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Vitamin E | 1994 |
[A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide].
Topics: Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Injections, Intravenous | 1994 |
Effect of 21-aminosteroid U74500A (pregna-1,4,9(11)-triene-3,20-dione, 21-(4-(5,6-bis(diethylamino)-2-pyridinyl)-1-piperazinyl)-16-methyl-, HCl (16 alpha)) on rat brain cortex lipid peroxidation induced "in vivo" by iron-carbohydrate.
Topics: Animals; Antioxidants; Cerebral Cortex; Ferric Compounds; Ferric Oxide, Saccharated; Fluorescence; Glucaric Acid; Lipid Peroxidation; Pregnatrienes; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 1994 |
Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide.
Topics: Adult; Anemia; Duodenal Ulcer; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iatrogenic Disease; Malabsorption Syndromes; Middle Aged; Osteomalacia | 1993 |
Repeated continuous administration of low doses of intravenous iron in anemic patients with active rheumatoid arthritis.
Topics: Anemia; Arthritis, Rheumatoid; C-Reactive Protein; Drug Administration Schedule; Erythrocyte Count; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Time Factors | 1993 |
Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
Topics: Administration, Oral; Adult; Aged; Anemia; Anemia, Iron-Deficiency; Delayed-Action Preparations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Follow-Up Studies; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors | 1996 |
Effects of iron salts in sucrose on dental caries and plaque in rats.
Topics: Acids; Anemia, Iron-Deficiency; Animals; Crystallization; Dental Caries; Dental Plaque; Diet, Cariogenic; Dietary Sucrose; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Glycerophosphates; Hydrogen-Ion Concentration; Incidence; Prevalence; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salivary Glands; Tooth Discoloration | 1997 |
The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures.
Topics: Aged; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Male; Methods; Middle Aged; Recombinant Proteins; Renal Dialysis; Sensitivity and Specificity; Transferrin | 1997 |
[Parenteral iron replacement].
Topics: Administration, Oral; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Administration Schedule; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex | 1997 |
Recombinant human erythropoietin to assist autologous blood donation by patients with anemia.
Topics: Anemia; Arthritis, Rheumatoid; Blood Donors; Blood Transfusion, Autologous; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Recombinant Proteins | 1997 |
Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin.
Topics: Administration, Oral; Adult; Aged; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Male; Middle Aged; Renal Dialysis; Retreatment; Treatment Outcome | 1997 |
[Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents].
Topics: Administration, Oral; Adolescent; Adult; Anemia; Blood Loss, Surgical; Child; Child, Preschool; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Postoperative Complications; Spinal Fusion; Sucrose | 1998 |
Gelatinous bone marrow transformation complicated by self-induced malnutrition.
Topics: Anorexia Nervosa; Bone Marrow; Citric Acid; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Middle Aged; Nutrition Disorders; Treatment Outcome | 1998 |
Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography.
Topics: Bone Marrow; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Liver; Sucrose; Tomography, Emission-Computed | 1999 |
Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography.
Topics: Adult; Anemia; Erythrocytes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Male; Middle Aged; Sucrose; Tomography, Emission-Computed; Transferrin | 1999 |
Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa.
Topics: Anemia, Iron-Deficiency; Child; Epidermolysis Bullosa Dystrophica; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Recombinant Proteins; Sucrose | 1999 |
Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats.
Topics: Administration, Oral; Adsorption; Animals; Calcium; Feces; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Phosphates; Random Allocation; Rats; Rats, Wistar; Structure-Activity Relationship; Sucrose; Time Factors | 1999 |
Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy.
Topics: Adult; Aged; Aged, 80 and over; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Glutathione Peroxidase; Humans; Injections, Intravenous; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; Reference Values; Renal Dialysis; Superoxide Dismutase | 1999 |
Quantification aspects of patient studies with 52Fe in positron emission tomography.
Topics: Adult; Bone Marrow; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart; Humans; Iron Radioisotopes; Liver; Myocardium; Phantoms, Imaging; Radiopharmaceuticals; Spleen; Tissue Distribution; Tomography, Emission-Computed | 1999 |
Improved response to erythropoietin therapy with long-term continuous iron supplementation.
Topics: Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Iron; Iron Overload; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis | 2000 |
Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia.
Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Pregnancy Outcome | 2000 |
[Iron deficiency. When parenteral substitution?].
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron | 2001 |
Iron sucrose or ferric gluconate?
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Renal Dialysis; Sucrose; Terminology as Topic | 2001 |
[Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation].
Topics: Adult; Anemia, Iron-Deficiency; Autoantibodies; Blood Preservation; Blood Transfusion, Autologous; Cryopreservation; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infant, Newborn; Injections, Intravenous; Iron; Pregnancy; Pregnancy Complications, Hematologic | 2002 |
Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.
Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Humans; Kidney Failure, Chronic; Male; Recombinant Proteins; Stroke Volume; Sucrose | 2001 |
Risk of bacterial infection in patients under intravenous iron therapy: dose versus length of treatment.
Topics: Adult; Bacterial Infections; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Middle Aged; Renal Dialysis; Sucrose | 2001 |
Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury.
Topics: Animals; Aorta; Cell Division; Cell Line; Cell Line, Transformed; Cell Survival; Chlorides; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Kidney Tubules, Proximal; Lipid Peroxidation; Male; Malondialdehyde; Mice; Oligosaccharides; Oxidants; Parenteral Nutrition | 2002 |
The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.
Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hospitalization; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Oxygen Consumption; Recombinant Proteins; Stroke Volume | 2002 |
Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Erythrocyte Indices; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infant; Infusions, Intravenous; Iron; Parenteral Nutrition; Reticulocyte Count; Time Factors | 2002 |
Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation.
Topics: Aged; Aged, 80 and over; Blood Proteins; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glycation End Products, Advanced; Humans; Inflammation; Infusions, Intravenous; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Renal Dialysis; Sodium Chloride; Sucrose | 2002 |
Continuity of research outcomes: the correlation of bench toxicity mechanisms to clinical outcomes--are they dependable?
Topics: Contraindications; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Tubules; Lipid Peroxidation; Oxidative Stress; Renal Dialysis | 2002 |
Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy.
Topics: Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gestational Age; Glucaric Acid; Hemoglobins; Humans; Injections, Intramuscular; Injections, Intravenous; Pregnancy; Pregnancy Complications; Prospective Studies; Treatment Outcome | 2002 |
Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Topics: Anemia, Iron-Deficiency; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fluorescence; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Recombinant Proteins; Renal Dialysis; Reticulocyte Count; Reticulocytes | 2003 |
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography.
Topics: Adult; Aged; Anemia; Erythrocytes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Iron Radioisotopes; Liver; Male; Middle Aged; Reticulocyte Count; Spleen; Tomography, Emission-Computed | 2003 |
Safety issues with iron sucrose.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Safety; Superoxides; Transferrin; Vasodilation | 2003 |
[Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
Topics: Aged; Aged, 80 and over; Anemia; Cost-Benefit Analysis; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spain; Sucrose | 2003 |
Vibrio vulnificus infection in a hemodialysis patient receiving intravenous iron therapy.
Topics: Aged; Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Male; Ostreidae; Renal Dialysis; Sucrose; Vibrio Infections; Vibrio vulnificus | 2003 |
Intravenous iron therapy with saccharated iron oxide.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds | 1952 |
[Hematological response of pregnant to saccharated iron oxide].
Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron Compounds; Pregnancy; Pregnancy Complications | 1952 |
Histological appearances following intravenous saccharated iron oxide, and the factors governing precipitation of the compound in vivo.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron Compounds | 1953 |
Experimental investigations on saccharated iron oxide.
Topics: Blood; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron Compounds | 1953 |
[Problem of the blood pressure reduction by iron saccharates].
Topics: Blood Pressure; Carbohydrates; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypotension; Iron | 1953 |
[Problem of the blood pressure reduction by iron saccharates].
Topics: Blood Pressure; Carbohydrates; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypotension; Iron | 1953 |
[The behavior of iron saccharates in the body and its therapeutic significance].
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1953 |
[Iron saccharate tolerance tests].
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1953 |
Toxic reactions after intravenous saccharated iron oxide in man; suggestions for improved preparations.
Topics: Administration, Intravenous; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Male | 1954 |
[The dosage of intravenous colloidal iron saccharates].
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1954 |
[Hemoglobin level in normal pregnancy after injection of colloidal iron saccharate].
Topics: Anemia; Anemia, Hypochromic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Iron; Pregnancy | 1954 |
[Stimulating effect of colloidal iron saccharates on bone marrow].
Topics: Bone Marrow; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1954 |
[Effect of experimental block of reticuloendothelial system with trypan blue and iron saccharate on anoxemic resistance in rat].
Topics: Animals; Coloring Agents; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hypoxia; Iron; Mononuclear Phagocyte System; Rats; Trypan Blue | 1954 |
[Measurement of the granulopectic activity of the reticuloendothelial system of the rat by means of saccharated iron oxide].
Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Mononuclear Phagocyte System; Rats | 1954 |
Iron therapy in pregnancy; a comparative study of various modes.
Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Iron; Pregnancy; Pregnancy Complications | 1954 |
Glomerular lesions and the nephrotic syndrome in rabbits given saccharated iron oxide intravenously; with special reference to the part played by intracapillary precipitates in the pathogenesis of the lesions.
Topics: Animals; Capillaries; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kidney; Kidney Diseases; Kidney Glomerulus; Nephrosis; Nephrotic Syndrome; Proteinuria; Rabbits | 1956 |
[Knowledge on injectible saccharated ferric oxide].
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Knowledge | 1956 |
[Injectable iron-oxide-sucrose].
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Oxides; Sucrose | 1956 |
[Effect of the injection of saccharated iron oxide on the phagocytic activity of the reticuloendothelial system in the rat].
Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Mononuclear Phagocyte System; Phagocytosis; Rats | 1956 |
[Information on injectable saccharated ferric oxide].
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1956 |
[Metabolism of radioiron-labeled, colloidal iron saccharate in man].
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron | 1956 |
[Experimental study with animals on injuries of the organ after administration of iron sucroses].
Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Siderosis | 1956 |
The cellular transformation of injected colloidal iron complexes into ferritin and hemosiderin in experimental animals; a study with the aid of electron microscopy.
Topics: Animals; Animals, Laboratory; Cytoplasm; Electrons; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemosiderin; Injections, Intraperitoneal; Iron; Liver; Macrophages; Mice; Microscopy; Microscopy, Electron; Pigments, Biological; Spleen | 1959 |
Staining of the retina with saccharated iron oxide.
Topics: Coloring Agents; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Retina; Staining and Labeling | 1959 |
Staining of fungi with saccharated iron oxide.
Topics: Coloring Agents; Ferric Compounds; Ferric Oxide, Saccharated; Fungi; Glucaric Acid; Iron; Staining and Labeling | 1959 |
Intranuclear aggregates of ferritin in liver cells of mice treated with saccharated iron oxide. Their possible relation to nuclear protein synthesis.
Topics: Animals; Cell Nucleus; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hepatocytes; Iron; Liver; Mice; Mice, Inbred DBA; Nuclear Proteins; Protein Biosynthesis | 1961 |
The reticuloendothelial system in the rabbit. Phagocytosis of saccharated iron oxide.
Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Mononuclear Phagocyte System; Phagocytosis; Rabbits | 1961 |
[On the problem of the effect of feeding of iron saccharate on the mutation rate induced by roentgen rays in Drosophila melanogaster].
Topics: Animals; Carbohydrates; Drosophila melanogaster; Ferric Compounds; Ferric Oxide, Saccharated; Genetics; Glucaric Acid; Iron; Mutation Rate; X-Rays | 1960 |
Experimental production of cholangitis and pancreatitis by ferric oxide saccharate (Fe-OS).
Topics: Cholangitis; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Pancreatitis | 1962 |
DISTRIBUTION OF INTRAVENOUSLY ADMINISTERED SACCHARATED IRON OXIDE IN THE POPLITEAL LYMPH NODE OF THE RABBIT.
Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Lymph Nodes; Lymphocytes; Physiology; Rabbits; Research | 1964 |
[Velocity of disappearance in plasma of saccharated iron oxide administered intravenously].
Topics: Cardiovascular System; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Function Tests; Humans; Iron; Plasma | 1954 |
Infusion of saccharated iron oxide in the treatment of iron deficiency anemia.
Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; North Carolina | 1962 |
Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report.
Topics: Anemia; Chronic Disease; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Radiation Injuries; Recombinant Proteins; Reticulocyte Count | 2003 |
[Use of venofer for iron deficiency correction in patients undergoing programmed hemodialysis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Sucrose; Treatment Outcome | 2003 |
Achieving optimal patient outcomes with intravenous iron.
Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Nurse-Patient Relations; Time Factors; Treatment Outcome | 2003 |
Reactivity of iron compounds.
Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron-Dextran Complex; Mice | 2003 |
Pharmacokinetics and utilization of iron sucrose.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kupffer Cells; Tissue Distribution | 2003 |
[Antiphospholipid antibodies as a cause of adverse pregnancy outcome. Therapeutic approach].
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heparin; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sucrose | 2003 |
Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Peritoneal Dialysis | 2003 |
Effect of iron sucrose on human peritoneal mesothelial cells.
Topics: Cell Division; Cell Survival; Cells, Cultured; Dialysis Solutions; Drug Interactions; Epithelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Free Radicals; Glucaric Acid; Humans; Interleukin-6; Peritoneal Cavity | 2003 |
Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemodialysis Solutions; Iron; Iron-Dextran Complex; Membranes, Artificial; Renal Dialysis | 2004 |
Labile iron in parenteral iron formulations: a quantitative and comparative study.
Topics: Biological Assay; Chemistry, Pharmaceutical; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Iron-Dextran Complex; Protein Binding; Sucrose; Transferrin | 2004 |
Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1951 |
Some effects of intravenous injections of saccharated iron oxide on serum iron and unsaturated iron binding capacity.
Topics: Blood; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematologic Tests; Humans; Injections, Intravenous; Iron | 1951 |
[Intravenous ferric saccharate therapy of iron deficiency anemia in gynecology].
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron | 1951 |
Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology.
Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron; Obstetrics; Pregnancy | 1951 |
[Colorimetric determination of iron in colloid iron-saccharate solutions].
Topics: Colloids; Colorimetry; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds | 1952 |
The hematologic response of the pregnant woman to intravenous saccharated iron oxide.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds; Pregnancy | 1952 |
[Constitution of ferri-3-saccharate].
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron Compounds | 1951 |
The immediate hematologic effects of intravenous saccharated iron oxide.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron Compounds; Leukocytes | 1952 |
Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products.
Topics: Anemia, Iron-Deficiency; Diarrhea; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypotension; Infusions, Intravenous; Male; Nausea; Prospective Studies; Renal Dialysis; Vomiting | 2004 |
The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure.
Topics: Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Nandrolone; Nandrolone Decanoate; Sucrose | 2004 |
Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation.
Topics: Blotting, Western; Cell Line; Citric Acid; Electrophoresis, Polyacrylamide Gel; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fluoresceins; Glucaric Acid; Humans; Iron; Oxidative Stress; Peroxides; Quaternary Ammonium Compounds; Renal Dialysis; Time Factors; Transferrin; Urea | 2004 |
Treatment of anaemia in inflammatory bowel disease with iron sucrose.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Retreatment; Retrospective Studies; Sucrose; Treatment Outcome | 2004 |
Parenteral iron nephrotoxicity: potential mechanisms and consequences.
Topics: Animals; Cell Line; Cytochromes c; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; In Vitro Techniques; Infusions, Parenteral; Iron; Iron-Dextran Complex; Kidney; Kidney Cortex; Kidney Diseases; Kidney Tubules, Proximal; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Microscopy, Electron; RNA, Messenger; Severity of Illness Index | 2004 |
Transferrin saturation with intravenous irons: an in vitro study.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; In Vitro Techniques; Infusions, Intravenous; Iron; Iron-Dextran Complex; Titrimetry; Transferrin | 2004 |
Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis.
Topics: Adult; Aged; Darbepoetin alfa; Enoxaparin; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematologic Agents; Humans; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2004 |
Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease.
Topics: Aged; Anemia; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron Deficiencies; Jehovah's Witnesses; Kidney Diseases; Middle Aged; Severity of Illness Index; Time Factors | 2004 |
[Safety and usefulness of parenteral iron in the management of anemia due to hip fracture in the elderly].
Topics: Aged; Aged, 80 and over; Anemia; Blood Loss, Surgical; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Infusions, Intravenous; Iron; Male; Sucrose | 2004 |
[Cooley's syndrome in the adult: treatment with intravenous iron saccharate].
Topics: Adult; Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1950 |
Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Biomarkers; Blood Chemical Analysis; Case-Control Studies; Chi-Square Distribution; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Humans; Incidence; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Reference Values; Renal Dialysis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sex Distribution; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Troponin T | 2004 |
[Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients].
Topics: Aged; Anemia, Iron-Deficiency; Ascorbic Acid; Biomarkers; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2004 |
[How to avoid a haemotransfusion which is not lifesaving? (our experience with administration of intravenous iron to pregnant women and young mothers)].
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Drug Administration Schedule; Erythrocyte Count; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gestational Age; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Sucrose | 2004 |
Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Infusions, Intravenous; Male; Postoperative Complications; Prospective Studies | 2005 |
Intravenous iron in a primary-care clinic.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Renal Insufficiency; Sucrose | 2005 |
Hypersensitivity reactions and deaths associated with intravenous iron preparations.
Topics: Adverse Drug Reaction Reporting Systems; Algorithms; Anaphylaxis; Drug Hypersensitivity; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron-Dextran Complex; Retrospective Studies; Severity of Illness Index; Sucrose; United States | 2005 |
Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients.
Topics: Anemia; Antioxidants; Ascorbic Acid; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Renal Dialysis | 2005 |
Ironing out the mystery of nephrotoxicity of parenteral iron.
Topics: Animals; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron-Dextran Complex; Kidney Diseases; Kidney Tubules; Oxidative Stress | 2005 |
Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats.
Topics: Animals; Blood Proteins; Blood Urea Nitrogen; Creatinine; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Iron-Dextran Complex; Kidney; Male; Organ Size; Phosphorus; Rats; Rats, Sprague-Dawley; Serum Albumin; Sodium | 2005 |
Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child.
Topics: Anemia, Iron-Deficiency; Chemical and Drug Induced Liver Injury; Child, Preschool; Deferoxamine; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Diseases; Glucaric Acid; Humans; Infusions, Intravenous; Liver Diseases; Male; Siderophores; Treatment Outcome | 2005 |
Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy.
Topics: Acute Disease; Animals; Cells, Cultured; Chemokine CCL2; Ferric Compounds; Ferric Oxide, Saccharated; Gene Expression; Glucaric Acid; Gluconates; Humans; Injections, Intravenous; Iron-Dextran Complex; Kidney Cortex; Kidney Diseases; Liver; Male; Mice; Mice, Inbred Strains; Oxidative Stress; Peritoneum; RNA, Messenger | 2005 |
Trends in intravenous iron use among dialysis patients in the United States (1994-2002).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hypochromic; Child; Child, Preschool; Drug Utilization; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Incidence; Infant; Infusions, Intravenous; Kidney Failure, Chronic; Male; Medicare; Middle Aged; Outpatients; Peritoneal Dialysis; Prevalence; Recombinant Proteins; Renal Dialysis; Retrospective Studies; United States | 2005 |
Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hepatic Insufficiency; Hepatitis C, Chronic; Humans; Injections, Intravenous; Kidney Failure, Chronic; Liver; Male; Middle Aged; Renal Dialysis; Retrospective Studies | 2005 |
Update on adverse drug events associated with parenteral iron.
Topics: Adverse Drug Reaction Reporting Systems; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron-Dextran Complex; Sucrose | 2006 |
Parenteral iron therapy: a single institution's experience over a 5-year period.
Topics: Acetaminophen; Anemia, Iron-Deficiency; Diphenhydramine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Hemorrhage; Glucaric Acid; Humans; Infusions, Parenteral; Iron Metabolism Disorders; Iron-Dextran Complex; Kidney Diseases; Male; Menorrhagia; Neoplasms; Premedication; Retrospective Studies; Telangiectasia, Hereditary Hemorrhagic; United States; von Willebrand Diseases | 2005 |
Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Pregnancy; Pregnancy Complications, Hematologic | 2005 |
Intravenous iron in the treatment of anemia of pregnancy. 1949.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; History, 20th Century; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Hematologic | 2005 |
Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin.
Topics: Anemia; Child; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Prospective Studies; Recombinant Proteins | 2005 |
Re: blood transfusion and orthognathic surgery a thing of the past?
Topics: Blood Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Oral Surgical Procedures; Sucrose | 2006 |
Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study.
Topics: Anemia, Refractory; C-Reactive Protein; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Interleukin-6; Male; Pilot Projects; Receptors, Transferrin; Transferrin; Treatment Outcome | 2006 |
Proinflammatory effects of iron sucrose in chronic kidney disease.
Topics: Aged; Chemokine CCL2; Chronic Disease; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammation; Kidney Diseases; Kidney Failure, Chronic; Reproducibility of Results | 2006 |
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
Topics: Anemia; Atorvastatin; Cardiology; Clinical Trials as Topic; Congresses as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Europe; Exercise Tolerance; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Societies, Medical; Xanthines | 2006 |
Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro.
Topics: Animals; Apoptosis; Cattle; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron-Dextran Complex; Signal Transduction; Stress, Physiological | 2006 |
Is i.v. iron really superior in CKD patients not on dialysis?
Topics: Administration, Oral; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Humans; Hypotension; Injections, Intravenous; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2006 |
Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients.
Topics: Aged; Anemia, Iron-Deficiency; Bacteremia; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Poisson Distribution; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Statistics, Nonparametric | 2006 |
Iron sucrose induced morphological and functional changes in the rat kidney.
Topics: Albuminuria; Animals; Body Weight; Creatinine; Diuresis; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Kidney; Male; Rats; Rats, Wistar; Urea | 2006 |
[Use of Venofer in management of anemia in cancer patients].
Topics: Adult; Aged; Anemia; Disease Progression; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasms; Quality of Life; Sucrose; Time Factors; Treatment Outcome | 2006 |
[Ferropenic anemia: some comments].
Topics: Anemia, Iron-Deficiency; Celiac Disease; Diagnosis, Differential; Ferric Compounds; Ferric Oxide, Saccharated; Folic Acid Deficiency; Glucaric Acid; Humans; Injections, Intravenous; Iron; Sucrose | 2006 |
[Budget impact analysis of a blood saving program for urgent traumatological surgery].
Topics: Administration, Oral; Age Factors; Aged, 80 and over; Anemia; Budgets; Confidence Intervals; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Iron; Length of Stay; Male; Recombinant Proteins | 2007 |
Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex.
Topics: Adult; Anemia, Iron-Deficiency; Breast Feeding; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron; Iron Deficiencies; Milk, Human; Postpartum Period; Puerperal Disorders | 2007 |
Coronary artery vasospasm with iron sucrose.
Topics: Coronary Vasospasm; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Middle Aged; Myocardial Ischemia | 2007 |
[Treatments of the martial deficiencies: preparations available in France].
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Humans; Iron; Iron Deficiencies | 2006 |
Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
Topics: Aged; Anemia, Iron-Deficiency; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hispanic or Latino; Humans; Infusions, Intravenous; Injections, Intravenous; Self Administration; Treatment Outcome | 2007 |
[Current recommendations for the treatment of iron deficiency anemia].
Topics: Anemia, Iron-Deficiency; Biomarkers; Drug Therapy, Combination; Epoetin Alfa; Erythrocyte Count; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Hematologic; Recombinant Proteins; Sucrose; Switzerland; Transferrin | 2007 |
Peritoneal effects of intravenous iron sucrose administration in rats.
Topics: Animals; Cells, Cultured; Dialysis Solutions; Drug Therapy, Combination; Eosinophils; Ferric Compounds; Ferric Oxide, Saccharated; Free Radicals; Glucaric Acid; Hematinics; Infusions, Intravenous; Iron; Leukocytes; Lipopolysaccharides; Macrophages, Peritoneal; Male; Pancreatic Elastase; Peritoneal Dialysis; Peritoneum; Peritonitis; Permeability; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2007 |
Intravenous iron.
Topics: Anemia; Drug Approval; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron-Dextran Complex; Molecular Weight; Renal Dialysis; United States; United States Food and Drug Administration | 2007 |
The safety of intravenous iron sucrose use in the elderly patient.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Geriatrics; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2007 |
Blood conservation in the critically ill.
Topics: Adult; Aged; Anemia; Baltimore; Blood; Blood Chemical Analysis; Clinical Protocols; Critical Care; Critical Illness; Drug Costs; Drug Monitoring; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Outcome and Process Assessment, Health Care; Pilot Projects; Recombinant Proteins | 2007 |
Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Postpartum Period; Pregnancy; Prevalence | 2005 |
Anemia and heart failure a new pathway?
Topics: Anemia, Iron-Deficiency; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hematinics; Humans; Infusions, Intravenous; Natriuretic Peptide, Brain; Peptide Fragments; Treatment Outcome | 2007 |
Chemical reactions of vitamin C with intravenous-iron formulations.
Topics: Animals; Ascorbic Acid; Cattle; Drug Interactions; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous | 2008 |
Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
Topics: Adult; Aged; C-Reactive Protein; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glutathione Peroxidase; Humans; Injections, Intravenous; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peritoneal Dialysis, Continuous Ambulatory; Sucrose | 2007 |
Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells.
Topics: Animals; Body Weight; Carcinoma, Hepatocellular; Cell Line, Tumor; Chick Embryo; Embryo, Nonmammalian; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Hematinics; Humans; Iron-Dextran Complex; Kidney; Liver; Liver Neoplasms; Nanoparticles; Survival Rate; Turkeys | 2008 |
Preparation and standardization of saccharated iron oxide for intra venous administration.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Reference Standards | 1949 |
Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia.
Topics: Aged; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Male | 2008 |
Intravenous treatment of anaemia with an iron-sucrose preparation.
Topics: Anemia; Anemia, Sickle Cell; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Sucrose | 1949 |
Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease.
Topics: Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Kidney Diseases; Male; Proteinuria; Renal Dialysis | 2008 |
A permanent tan from iron.
Topics: Aged; Anemia, Iron-Deficiency; Arm; Extravasation of Diagnostic and Therapeutic Materials; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hyperpigmentation | 2008 |
Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery.
Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Orthopedic Procedures; Preoperative Care | 2008 |
Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infant; Infusions, Intravenous; Male; Prospective Studies; Treatment Outcome | 2008 |
Parenteral iron therapy.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Infusions, Parenteral; Iron; Patient Compliance | 2008 |
Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection.
Topics: Adult; Aged; Catalysis; Electron Spin Resonance Spectroscopy; Female; Ferric Compounds; Ferric Oxide, Saccharated; Free Radicals; Glucaric Acid; Hematinics; Humans; Iron; Lipoproteins, LDL; Male; Middle Aged; Models, Biological; Oxidative Stress | 2008 |
Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients.
Topics: Brachial Artery; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Ultrasonography; Vasodilation | 2008 |
Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients.
Topics: Aged; Anemia, Iron-Deficiency; Centers for Medicare and Medicaid Services, U.S.; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome; United States | 2009 |
Use of iron sucrose in dialysis patients sensitive to iron dextran.
Topics: Adult; Aged; Anemia, Iron-Deficiency; Dialysis Solutions; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Humans; Iron-Dextran Complex; Male; Middle Aged; Renal Dialysis; Treatment Outcome; Young Adult | 2009 |
The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
Topics: Adult; Aged; Anemia; Comorbidity; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Renal Dialysis; Retrospective Studies; Survival Analysis; Transferrin | 2009 |
[Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients].
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Male; Middle Aged; Preoperative Care; Prospective Studies | 2009 |
Intravenous iron sucrose changes the intraperitoneal homeostasis.
Topics: Adult; Aged; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Dialysis Solutions; Endothelium; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Interleukin-6; Iron; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Permeability; Uremia | 2009 |
Treatment of restless legs syndrome with iron infusion therapy.
Topics: Continuous Positive Airway Pressure; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Middle Aged; Restless Legs Syndrome; Sleep Apnea, Obstructive | 2009 |
Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Topics: Anemia, Iron-Deficiency; Drug-Related Side Effects and Adverse Reactions; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Sucrose | 2009 |
Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
Topics: Adult; Anemia; Cohort Studies; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Renal Dialysis; Retrospective Studies; Transferrin | 2009 |
Differences between original intravenous iron sucrose and iron sucrose similar preparations.
Topics: Animals; Biomarkers; Blood Pressure; Chemistry, Pharmaceutical; Creatinine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Heart; Hematinics; Hemodynamics; Immunohistochemistry; Inflammation; Injections, Intravenous; Kidney; Liver; Male; Myocardium; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley | 2009 |
Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.
Topics: Adult; Aged, 80 and over; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Humans; Hypophosphatemia; Injections, Intravenous; Male; Middle Aged | 2009 |
A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical ou
Topics: Aged; Aged, 80 and over; Anemia; Chronic Disease; Cohort Studies; Drug Evaluation; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Neurotransmitter Agents; Pilot Projects; Prospective Studies; Recombinant Proteins; Survival Rate; Syndrome; Time Factors; Treatment Outcome | 2009 |
Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Biomarkers; Blood Chemical Analysis; Bone Marrow; Bone Marrow Examination; Chi-Square Distribution; Chronic Disease; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron; Kidney Diseases; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Time Factors; Transferrin; Treatment Outcome; Young Adult | 2010 |
Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma.
Topics: Animals; Comparative Genomic Hybridization; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gene Deletion; Gene Expression Profiling; Genes, p16; Glucaric Acid; Hematinics; Male; Mesoderm; Mesothelioma; Mucoproteins; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Peritoneal Neoplasms; Rats; Rats, Inbred F344; Rats, Wistar; Transcription Factors; Uromodulin | 2010 |
Letter 2: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128).
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Colorectal Neoplasms; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Postoperative Complications; Preoperative Care; Randomized Controlled Trials as Topic | 2010 |
Letter 1: Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery (Br J Surg 2009; 96: 1122-1128).
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Colorectal Neoplasms; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Postoperative Complications; Randomized Controlled Trials as Topic | 2010 |
[Treating severe acute anemia due to vaginal bleeding in the Jehovah's Witness: a report of 2 cases].
Topics: Adult; Anemia; Anti-Anxiety Agents; Anticoagulants; Cervix Uteri; Combined Modality Therapy; Contraceptives, Oral, Hormonal; Dalteparin; Embolization, Therapeutic; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Immobilization; Jehovah's Witnesses; Menorrhagia; Oxygen Inhalation Therapy; Parenteral Nutrition; Postpartum Hemorrhage; Pregnancy; Recombinant Proteins; Thromboembolism; Treatment Refusal; Young Adult | 2009 |
Iron replacement therapy: assessing today's options to prepare for bundling.
Topics: Anemia, Iron-Deficiency; Chemistry, Pharmaceutical; Dextrans; Drug Costs; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Medicare; Reimbursement Mechanisms; Renal Dialysis; Risk Adjustment; Safety; Sucrose; Treatment Outcome; United States | 2010 |
Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis.
Topics: Aged; Aged, 80 and over; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors | 2010 |
Delayed adverse reactions to iron polymaltose and iron sucrose.
Topics: Dizziness; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Diseases; Glucaric Acid; Humans; Time Factors | 2010 |
Eosinophilic fasciitis secondary to intravenous iron infusions.
Topics: Adult; Anemia, Iron-Deficiency; Eosinophilia; Fasciitis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous | 2010 |
Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Blood Urea Nitrogen; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Chemokine CCL2; Disease Models, Animal; Endotoxins; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Gene Expression Regulation; Glucaric Acid; Gluconates; Glycerol; Heme Oxygenase-1; Humans; Injections, Intravenous; Kidney Tubules, Proximal; Lipocalin-2; Lipocalins; Membrane Proteins; Mice; Oncogene Proteins; Oxidative Stress; Proto-Oncogene Proteins; RNA, Messenger | 2010 |
[Treatment with intravenous iron and ferritin level].
Topics: Anemia; Blood Proteins; Case-Control Studies; Clinical Protocols; Drug Monitoring; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Oxidation-Reduction; Prospective Studies; Renal Dialysis | 2010 |
Response to iron sucrose in dialysis patients sensitive to iron dextran.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron-Dextran Complex; Renal Dialysis | 2010 |
Influence of intravenous iron therapy on novel markers of iron deficiency.
Topics: Anemia, Iron-Deficiency; Biomarkers; Cross-Sectional Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Reticulocytes; Time Factors; Transferrin; Treatment Outcome | 2010 |
The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2011 |
In vitro study on the effects of iron sucrose, ferric gluconate and iron dextran on redox-active iron and oxidative stress.
Topics: Cell Survival; Dextrans; Ferric Compounds; Ferric Oxide, Saccharated; Free Radical Scavengers; Glucaric Acid; Hep G2 Cells; Humans; Iron; Oxidation-Reduction; Reactive Oxygen Species | 2010 |
Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival.
Topics: CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; GPI-Linked Proteins; Humans; Iron-Dextran Complex; Lymphocyte Subsets; Molecular Weight; Oxidative Stress; Reactive Oxygen Species; Receptors, IgG; Sucrose | 2010 |
Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management.
Topics: Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Preoperative Care | 2010 |
The therapeutic equivalence of complex drugs.
Topics: Anticoagulants; Biological Products; Congresses as Topic; Consumer Product Safety; Drugs, Generic; Evidence-Based Medicine; Ferric Compounds; Ferric Oxide, Saccharated; Glatiramer Acetate; Glucaric Acid; Hematinics; Heparin, Low-Molecular-Weight; Humans; Immunosuppressive Agents; Legislation, Drug; Liposomes; Patents as Topic; Peptides; Proteins; Risk Assessment; Sucrose; Therapeutic Equivalency | 2011 |
The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia, Iron-Deficiency; Cost-Benefit Analysis; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Health Care Costs; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Male; Maltose; Middle Aged; Young Adult | 2010 |
Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans | 2010 |
Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran.
Topics: Adult; Aged; Dextrans; Female; Ferric Compounds; Ferric Oxide, Saccharated; Free Radicals; Glucaric Acid; Humans; Iron; Male; Middle Aged; Oxidative Stress; Protein Carbonylation; Renal Dialysis | 2011 |
Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Young Adult | 2011 |
Should intravenous iron be upfront therapy for iron deficiency anemia?
Topics: Anemia, Iron-Deficiency; Child; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron-Dextran Complex; Molecular Weight | 2011 |
Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy.
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infant; Infusions, Intravenous; Male | 2011 |
Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients.
Topics: Adult; Aged; Anemia; Dextrans; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis | 2011 |
Physicochemical and toxicological characterization of a new generic iron sucrose preparation.
Topics: Algorithms; Animals; Chromatography, Gel; Chromatography, High Pressure Liquid; Creatinine; Drugs, Generic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Iron; Kinetics; Liver Function Tests; Microscopy, Atomic Force; Molecular Weight; Nephelometry and Turbidimetry; Particle Size; Polarography; Proteinuria; Rats; Rats, Sprague-Dawley; Reference Standards; Superoxide Dismutase | 2011 |
Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients.
Topics: Aged; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis; Vitamin D | 2011 |
Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients.
Topics: Adult; Aged; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Humans; Iron-Dextran Complex; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Retrospective Studies | 2011 |
New rat models of iron sucrose-induced iron overload.
Topics: Animals; Antimicrobial Cationic Peptides; Biomarkers; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Gene Expression; Glucaric Acid; Hepcidins; Humans; Inflammation; Iron; Iron Overload; Lipid Peroxidation; Liver; Oxidative Stress; Rats; Serum; Time Factors | 2011 |
Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America.
Topics: Anaphylaxis; Drug Hypersensitivity; Europe; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron Compounds; Iron-Dextran Complex; North America; Odds Ratio; United States; United States Food and Drug Administration | 2011 |
IBD: Intravenous iron in IBD--what's the best preparation?
Topics: Anemia, Iron-Deficiency; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Maltose; Quality of Life; Treatment Outcome | 2011 |
A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Costs and Cost Analysis; Elective Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Maltose; Middle Aged; Preoperative Care | 2011 |
Analysis of total and transferrin-bound iron in human serum for pharmacokinetic studies of iron-sucrose formulations.
Topics: Anemia, Iron-Deficiency; Colorimetry; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Reproducibility of Results; Spectrophotometry; Transferrin | 2011 |
Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model.
Topics: Animals; Antioxidants; Blood Pressure; Creatinine; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Heart; Hematinics; Immunohistochemistry; Inflammation; Injections, Intravenous; Iron-Dextran Complex; Kidney; Lipid Peroxidation; Liver; Magnetite Nanoparticles; Male; Maltose; Molecular Weight; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley | 2011 |
Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients.
Topics: Adult; Aged; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Dialysis | 2012 |
Modulation of Pseudomonas aeruginosa lipopolysaccharide-induced lung inflammation by chronic iron overload in rat.
Topics: Analysis of Variance; Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cytokines; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Overload; Lipopolysaccharides; Lung; Male; Peroxidase; Pneumonia; Pseudomonas aeruginosa; Rats; Rats, Wistar; Weaning | 2012 |
Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model.
Topics: Animals; Biomarkers; Blood Pressure; Creatinine; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Immunohistochemistry; Inflammation; Injections, Intravenous; Iron; Iron-Dextran Complex; Kidney; Liver; Liver Function Tests; Male; Molecular Weight; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2011 |
[Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide].
Topics: Aged; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Hypophosphatemia; Male; Osteomalacia | 2011 |
Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
Topics: Adult; Anemia, Iron-Deficiency; Drugs, Generic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron, Dietary; Middle Aged; Therapeutic Equivalency; Young Adult | 2012 |
Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration.
Topics: Animals; Aorta, Thoracic; Cell Adhesion; Cell Survival; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; In Vitro Techniques; Male; Monocytes; Rats; Rats, Sprague-Dawley; Vasodilation | 2012 |
Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model.
Topics: Anemia, Iron-Deficiency; Animals; Disease Models, Animal; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Inflammation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2012 |
Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi.
Topics: Academic Medical Centers; Adult; Anemia, Iron-Deficiency; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecologic Surgical Procedures; Hematinics; Humans; Pakistan; Preoperative Care; Recombinant Proteins; Reticulocyte Count; Time Factors; Treatment Outcome | 2011 |
Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.
Topics: Adult; Anemia; Apoptosis; Carbohydrates; Escherichia coli; Female; Ferric Compounds; Ferric Oxide, Saccharated; Flow Cytometry; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Male; Neutrophils; Phagocytosis; Staphylococcus aureus; Time Factors | 2012 |
Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia.
Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Blood Transfusion; Cohort Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Maltose; Puerperal Disorders; Retrospective Studies; Treatment Outcome | 2012 |
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement.
Topics: Aged; Anemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hematinics; Hospital Mortality; Humans; Infusions, Intravenous; Male; Postoperative Period; Preoperative Care; Prospective Studies; Recombinant Proteins; Risk Factors; Spain; Sucrose; Survival Rate; Treatment Outcome | 2012 |
Changing patterns of anemia management in US hemodialysis patients.
Topics: Adolescent; Adult; Aged; Anemia; Child; Child, Preschool; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron Compounds; Kidney Failure, Chronic; Male; Middle Aged; Practice Patterns, Physicians'; Renal Dialysis; Time Factors; United States | 2012 |
Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.
Topics: Administration, Intravenous; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Maltose; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Retrospective Studies; Young Adult | 2012 |
Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies.
Topics: Animals; Drug Approval; Drugs, Generic; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Metal Nanoparticles; Therapeutic Equivalency | 2012 |
Comparative rates of adverse events with different formulations of intravenous iron.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Multivariate Analysis; Retrospective Studies | 2012 |
Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.
Topics: Absorptiometry, Photon; Adult; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Osteomalacia; Phosphorus; Time Factors; Treatment Outcome; Withholding Treatment | 2012 |
An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic.
Topics: Administration, Intravenous; Ambulatory Care Facilities; Anemia, Iron-Deficiency; Clinical Protocols; Costs and Cost Analysis; Decision Support Techniques; Efficiency, Organizational; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hospitalization; Humans; Maltose; Patient Preference; Renal Insufficiency, Chronic; Transportation; United Kingdom | 2013 |
eComment. The problem of anaemia correction in cardiac surgery patients.
Topics: Anemia, Iron-Deficiency; Blood Transfusion; Cardiac Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Male; Sucrose | 2012 |
[Preoperative intravenous iron as a strategy for blood saving in surgery for hip fracture].
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Blood Transfusion; Case-Control Studies; Cross Infection; Drug Evaluation; Erythrocyte Transfusion; Erythropoiesis; Female; Femoral Neck Fractures; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Fractures; Humans; Infusions, Intravenous; Male; Postoperative Complications; Premedication; Preoperative Care; Retrospective Studies; Surgical Wound Infection | 2013 |
Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients.
Topics: Administration, Intravenous; Adult; Anemia, Iron-Deficiency; Confidence Intervals; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Medical Audit; Middle Aged; Obstetric Surgical Procedures; Postpartum Period; Pregnancy; Pregnancy Complications, Hematologic; Republic of Korea; Retrospective Studies | 2013 |
Uncommon adverse effect of a common medication.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Low Back Pain; Magnetic Resonance Imaging; Middle Aged; Osteomalacia; Pelvic Pain; Remission Induction; Treatment Outcome | 2013 |
Clinical efficacy of two forms of intravenous iron--saccharated ferric oxide and cideferron--for iron deficiency anemia.
Topics: Aged; Aging; Anemia, Hypochromic; Asian People; Colloids; Contrast Media; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Sex Characteristics | 2012 |
Adverse reaction to intravenous iron: hypersensitivity or secondary side effect?
Topics: Adult; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Sucrose | 2013 |
Optimizing preoperative haemoglobin with intravenous iron.
Topics: Adult; Aged; Aged, 80 and over; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobinometry; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Orthopedic Procedures; Recombinant Proteins; Young Adult | 2013 |
A case study of an iron-deficient female Olympic 1500-m runner.
Topics: Adolescent; Anemia, Iron-Deficiency; Athletes; Athletic Performance; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Lactic Acid; Oxygen Consumption; Running; Sucrose; Young Adult | 2013 |
Iatrogenic osteomalacia: report of two cases.
Topics: Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gastrectomy; Glucaric Acid; Humans; Hypophosphatasia; Iatrogenic Disease; Male; Middle Aged; Osteomalacia; Postoperative Complications; Vitamin D Deficiency | 2013 |
Managing severe anemia when the patient is a Jehovah's Witness.
Topics: Adult; Anemia, Iron-Deficiency; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Fluid Therapy; Glucaric Acid; Hematinics; Humans; Jehovah's Witnesses; Male; Oxygen Inhalation Therapy; Recombinant Proteins; Severity of Illness Index; Vitamin B 12; Vitamin B Complex | 2013 |
Oxidative effect of several intravenous iron complexes in the rat.
Topics: Administration, Intravenous; Animals; Dinitrobenzenes; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron-Dextran Complex; Maltose; Oxidative Stress; Rats; Tissue Distribution; Tyrosine | 2013 |
Physicochemical and structural characterization of iron-sucrose formulations: a comparative study.
Topics: Anemia, Iron-Deficiency; Chromatography, Gel; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Sucrose | 2014 |
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey.
Topics: Anemia, Iron-Deficiency; Central Venous Catheters; Ferric Compounds; Ferric Oxide, Saccharated; France; Glucaric Acid; Humans; Infusions, Intravenous; Maltose; Neoplasms; Practice Patterns, Physicians'; Surveys and Questionnaires | 2013 |
Clinical and biochemical improvement following low-dose intravenous iron therapy in a patient with erythropoietic protoporphyria.
Topics: Administration, Intravenous; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Male; Protoporphyria, Erythropoietic; Sucrose; Treatment Outcome; Young Adult | 2013 |
[Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia, Iron-Deficiency; Child; Child, Preschool; Cost Savings; Cross-Sectional Studies; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobinometry; Humans; Infant; Infusions, Intravenous; Iron Compounds; Male; Maltose; Middle Aged; National Health Programs; Off-Label Use; Retrospective Studies; Switzerland; Young Adult | 2013 |
Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Age of Onset; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Male; Nocturnal Myoclonus Syndrome; Polysomnography; Restless Legs Syndrome; Retrospective Studies | 2013 |
Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin.
Topics: Administration, Intravenous; Adult; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Pregnancy; Pregnancy Complications; Restless Legs Syndrome; Treatment Outcome | 2013 |
Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Blood Transfusion; Feasibility Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pilot Projects; Prospective Studies; Quality of Life; Treatment Outcome | 2013 |
Use of intravenous iron sucrose for treatment of anaemia in pregnancy.
Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Hematologic | 2013 |
Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy.
Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies | 2013 |
Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data.
Topics: Anemia, Iron-Deficiency; Budgets; Cost Savings; Drug Substitution; Female; Ferric Compounds; Ferric Oxide, Saccharated; Financing, Personal; Glucaric Acid; Humans; Maltose; National Health Programs; Switzerland | 2014 |
Ferumoxytol: an intravenous iron, riskier than iron sucrose.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Clinical Trials as Topic; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans | 2013 |
Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.
Topics: Anemia, Iron-Deficiency; Biological Availability; Cell Culture Techniques; Dose-Response Relationship, Drug; Drug Liberation; Drug Stability; Drugs, Generic; Enzyme-Linked Immunosorbent Assay; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hep G2 Cells; Humans; Injections, Intravenous; Macrophages; Spectrophotometry, Atomic; Sucrose | 2015 |
Hepcidin production in response to iron is controlled by monocyte-derived humoral factors.
Topics: Animals; Cell Line; Coculture Techniques; Cytokines; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hep G2 Cells; Hepcidins; Humans; Iron; Leukocytes, Mononuclear; Male; Monocytes; Rats; Spleen; Transferrin | 2014 |
Hydroxyurea could be a good clinically relevant iron chelator.
Topics: Animals; Antisickling Agents; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hydroxyurea; Iron Chelating Agents; Iron Overload; Liver; Male; Mice; Mice, Inbred BALB C; Myocardium; Time Factors | 2013 |
Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose.
Topics: Chemistry, Pharmaceutical; Colloids; Drug Stability; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Thermodynamics | 2014 |
Identification of the sentinel node by ultrasonography in patients with breast cancer.
Topics: Adult; Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Breast Neoplasms, Male; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Image-Guided Biopsy; Lymph Nodes; Male; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Signal Processing, Computer-Assisted; Sucrose; Technetium; Ultrasonography; Young Adult | 2014 |
Successful treatment with 532-nm Q-switched Nd:YAG laser of cutaneous siderosis following intravenous iron extravasation.
Topics: Aged; Anemia, Iron-Deficiency; Extravasation of Diagnostic and Therapeutic Materials; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Lasers, Solid-State; Male; Skin Diseases; Sucrose | 2015 |
The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis.
Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fibrinogen; Glucaric Acid; Hemoglobins; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Renal Dialysis; ROC Curve; Sucrose | 2013 |
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.
Topics: Animals; Atherosclerosis; Cell Adhesion; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Intercellular Adhesion Molecule-1; Leukocytes; Lipid Peroxidation; Male; Mice, Inbred C57BL; Monocytes; NF-kappa B; Renal Insufficiency, Chronic; Superoxides; U937 Cells; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2014 |
Rapid iron desensitization after generalized urticaria and facial angioedema.
Topics: Anemia, Iron-Deficiency; Angioedema; Desensitization, Immunologic; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Middle Aged; Sucrose; Urticaria | 2014 |
The uptake of particulate matter by endothelial cells.
Topics: Adrenal Glands; Animals; Endothelial Cells; Endothelium, Vascular; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Horses; Kupffer Cells; Liver; Mice; Myocardium; Rats; Spleen | 1967 |
Cell viability and chondrogenic differentiation capability of human mesenchymal stem cells after iron labeling with iron sucrose.
Topics: Adolescent; Adult; Aggrecans; Biomarkers; Cell Differentiation; Cell Survival; Cells, Cultured; Chondrocytes; Chondrogenesis; Collagen Type II; Ferric Compounds; Ferric Oxide, Saccharated; Flow Cytometry; Gene Expression; Glucaric Acid; Humans; Immunohistochemistry; Immunophenotyping; Iron; Mesenchymal Stem Cells; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; SOX9 Transcription Factor; Staining and Labeling; Sucrose; Time Factors; Transforming Growth Factor beta; Young Adult | 2014 |
Nitrosative Stress and Apoptosis by Intravenous Ferumoxytol, Iron Isomaltoside 1000, Iron Dextran, Iron Sucrose, and Ferric Carboxymaltose in a Nonclinical Model.
Topics: Administration, Intravenous; Animals; Apoptosis; Caspase 3; Disaccharides; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron-Dextran Complex; Kidney; Liver; Male; Maltose; Models, Animal; Myocardium; Rats; Tyrosine | 2015 |
Anemia in the critically ill: do we need to live with it?*.
Topics: Anemia; Critical Illness; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male | 2014 |
Assessment of the introduction of a blood management program in orthopaedic surgery.
Topics: Aged; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Blood Banks; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Hospitals, University; Humans; Length of Stay; Male; Middle Aged; Operative Blood Salvage; Orthopedics; Postoperative Hemorrhage; Program Evaluation; Retrospective Studies; Spain; Tranexamic Acid | 2015 |
Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity.
Topics: Ascorbic Acid; Cell Line; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hep G2 Cells; Humans; Iron; Liver; Macrophages; Maltose | 2015 |
Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator.
Topics: Animals; Apoptosis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Injections, Intradermal; Interleukin-6; Liver; Male; Rats, Sprague-Dawley; Reactive Nitrogen Species; Stress, Physiological; Sucrose; Tumor Necrosis Factor-alpha | 2015 |
Intravenous iron sucrose for children with iron deficiency anemia: a single institution study.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infant; Male; Retrospective Studies | 2016 |
Gastric Antral Vascular Ectasia (GAVE): an overlooked diagnosis.
Topics: Aged; Argon Plasma Coagulation; Endoscopy, Digestive System; Female; Ferric Compounds; Ferric Oxide, Saccharated; Folic Acid; Gastric Antral Vascular Ectasia; Gastrointestinal Hemorrhage; Gastroscopy; Glucaric Acid; Humans; Treatment Outcome | 2015 |
Electrophysiological and molecular mechanisms of protection by iron sucrose against phosphine-induced cardiotoxicity: a time course study.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Death; Electrocardiography; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Diseases; Heart Rate; Hydroxyl Radical; Insecticides; Lipid Peroxidation; Male; Mitochondria, Heart; Myocardium; Phosphines; Rats; Rats, Wistar | 2015 |
Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations.
Topics: Animals; Cation Transport Proteins; Cell Line; Cell Survival; Disaccharides; Epithelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrosoferric Oxide; Glucaric Acid; Hepcidins; Humans; Iron; Iron-Dextran Complex; Kidney; Lipid Peroxidation; Macrophages, Peritoneal; Maltose; Oxidative Stress; Primary Cell Culture; Rats; Tumor Necrosis Factor-alpha | 2015 |
Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness.
Topics: Aged; Anemia; Aortic Aneurysm, Abdominal; Blood Loss, Surgical; Critical Illness; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron Compounds; Jehovah's Witnesses; Male; Recombinant Proteins; Salvage Therapy | 2015 |
Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Biomarkers, Tumor; Calbindin 2; Cell Cycle Proteins; Cell Line, Tumor; Chromosome Deletion; Deoxyguanosine; Down-Regulation; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Iron Overload; Lung Neoplasms; Male; Membrane Glycoproteins; Mesothelioma; Mesothelioma, Malignant; Neoplasms, Experimental; Nuclear Proteins; Rats; Rats, Wistar; RNA Splicing Factors; Thromboxane-A Synthase | 2015 |
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
Topics: Administration, Intravenous; Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Renal Dialysis; Renal Insufficiency, Chronic; Stroke; United States | 2015 |
Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.
Topics: Anemia, Iron-Deficiency; Cohort Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Time Factors | 2016 |
Transport of sucrose-modified nanoscale zero-valent iron in saturated porous media: role of media size, injection rate and input concentration.
Topics: Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Groundwater; Iron; Kinetics; Metal Nanoparticles; Porosity; Silicon Dioxide; Sucrose; Suspensions | 2015 |
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
Topics: Aged; Anaphylaxis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Gluconates; Humans; Incidence; Injections, Intravenous; Iron-Dextran Complex; Male; Medicare Part A; Retrospective Studies; Risk; United States | 2015 |
Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers.
Topics: Adult; Aged; Anemia; Antioxidants; Area Under Curve; C-Reactive Protein; Case-Control Studies; Critical Illness; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Healthy Volunteers; Humans; Infusions, Intravenous; Interleukin-6; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress | 2016 |
Potential of Alginate Encapsulated Ferric Saccharate Microemulsions to Ameliorate Iron Deficiency in Mice.
Topics: Alginates; Anemia, Iron-Deficiency; Animals; Biological Availability; Caco-2 Cells; Cells, Cultured; Emulsions; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glucuronic Acid; Hexuronic Acids; Humans; Male; Mice | 2016 |
In Vitro Release Kinetics and Transferrin Saturation Study of Intravenous Iron Sucrose Entrapped in Poly(ethylene glycol)-Assisted Silica Xerogel.
Topics: Drug Carriers; Drug Delivery Systems; Drug Liberation; Ferric Compounds; Ferric Oxide, Saccharated; Gels; Glucaric Acid; Humans; Kinetics; Polyethylene Glycols; Silicon Dioxide; Transferrin | 2016 |
Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
Topics: Aged; Anemia; Darbepoetin alfa; Disease Management; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Models, Statistical; Neural Networks, Computer; Renal Dialysis; Retrospective Studies | 2016 |
Ferrous iron content of intravenous iron formulations.
Topics: Administration, Intravenous; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Ferrous Compounds; Glucaric Acid; Iron-Dextran Complex; Maltose | 2016 |
Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy.
Topics: Administration, Intravenous; Chemistry, Pharmaceutical; Drug Compounding; Dynamic Light Scattering; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Ferrous Compounds; Glucaric Acid; Iron-Dextran Complex; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Temperature | 2016 |
Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Dietary Supplements; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Parenteral; Male; Republic of Korea; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
Topics: Anemia; Animals; Cardiotonic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Fibrosis; Glucaric Acid; Inflammation; Infusions, Intravenous; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tyrosine; Ventricular Remodeling | 2016 |
Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).
Topics: Acute Disease; Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron-Dextran Complex; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome | 2016 |
Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.
Topics: Acute Kidney Injury; alpha 1-Antitrypsin; Alpha-Globulins; Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Glycerol; Haptoglobins; Heme Oxygenase-1; Hemopexin; Hepcidins; Interleukin-10; Kidney; Male; Maleates; Metalloporphyrins; Mice; Protective Agents; Protoporphyrins; RNA, Messenger; Troponin C | 2016 |
Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells.
Topics: Anemia, Iron-Deficiency; Case-Control Studies; Cell Differentiation; Dendritic Cells; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Iron Compounds; Macrophages; Maltose; MicroRNAs; Monocytes; Phagocytosis | 2016 |
[Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
Topics: Adult; Anemia; Biomarkers; Disease Progression; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Glucuronidase; Hematinics; Hemoglobins; Humans; Iron; Klotho Proteins; Male; Middle Aged; Outcome Assessment, Health Care; Renal Dialysis; Renal Insufficiency, Chronic; Severity of Illness Index | 2016 |
Correction of Iron Deficiency Anemia With Intravenous Iron Sucrose in Children With Inflammatory Bowel Disease.
Topics: Adolescent; Anemia, Iron-Deficiency; C-Reactive Protein; Child; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Gastrointestinal Agents; Glucaric Acid; Hemoglobins; Humans; Inflammatory Bowel Diseases; Infliximab; Injections, Intravenous; Iron; Male; Prospective Studies | 2016 |
Is there any role of intravenous iron for the treatment of anemia in cancer?
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
AMD-like retinopathy associated with intravenous iron.
Topics: Animals; Apoferritins; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Gene Expression Regulation; Glucaric Acid; Injections, Intravenous; Iron; Macular Degeneration; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Real-Time Polymerase Chain Reaction; Receptors, Transferrin; Retinal Pigment Epithelium; RNA | 2016 |
Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
Topics: Administration, Intravenous; Adolescent; Anemia, Iron-Deficiency; Child; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Male; Maltose; Portugal; Prospective Studies; Transferrin | 2017 |
Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice.
Topics: Administration, Oral; Animals; Baroreflex; Curcumin; Deferiprone; Disease Models, Animal; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hypertension; Iron Chelating Agents; Iron Overload; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Pyridones | 2016 |
Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Complement Activation; Complement C1q; Complement C3d; Complement Membrane Attack Complex; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; In Vitro Techniques; Iron Compounds; Iron-Dextran Complex; Kidney Failure, Chronic; Maltose; Mannose-Binding Lectin; Properdin; Renal Dialysis | 2017 |
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).
Topics: Adult; Aged; Anemia; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; France; Glucaric Acid; Hematologic Neoplasms; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Retrospective Studies | 2017 |
Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
Topics: Administration, Intravenous; Aged; Anemia; Cardiovascular Diseases; Cause of Death; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infections; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Proportional Hazards Models; Renal Dialysis; Retrospective Studies | 2017 |
Validation of a quantitative susceptibility mapping acquisition and reconstruction pipeline using a new iron sucrose based MR susceptibility phantom.
Topics: Equipment Design; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Phantoms, Imaging | 2017 |
Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblasts; Glucaric Acid; Hep G2 Cells; Humans; Iron; Kidney; Mice; Oxidative Stress; Up-Regulation; Ureteral Obstruction | 2017 |
A Toddler With Severe Anemia, Pica, and Extremity Swelling.
Topics: Anemia; Blood Transfusion; Edema; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Foot; Glucaric Acid; Hematinics; Humans; Infant; Male; Oxygen Inhalation Therapy; Pica | 2017 |
Intravenous Iron Sucrose for Children With Iron Deficiency Anemia.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Erythrocyte Indices; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infant; Iron; Male; Young Adult | 2017 |
Tin protoporphyrin activates the oxidant-dependent NRF2-cytoprotective pathway and mitigates acute kidney injury.
Topics: Acute Kidney Injury; Animals; Ferric Compounds; Ferric Oxide, Saccharated; Gene Expression Regulation; Glucaric Acid; Male; Metalloporphyrins; Mice; NF-E2-Related Factor 2; Oxidants; Protein Binding; Protoporphyrins; Reperfusion Injury | 2017 |
Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia.
Topics: Anemia; Animals; Disease Models, Animal; Dogs; Erythrocyte Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron; Lung Injury; Mortality; Pneumonia, Bacterial; Pneumonia, Staphylococcal | 2017 |
Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells.
Topics: Ascorbic Acid; Catalase; Cell Survival; Colonic Neoplasms; Deferoxamine; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; HCT116 Cells; HT29 Cells; Humans; Hydrogen Peroxide; Iron; Iron Chelating Agents; Oxidative Stress | 2018 |
A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report.
Topics: Bone Density; Female; Ferric Compounds; Ferric Oxide, Saccharated; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucaric Acid; Hematinics; Humans; Hypocalcemia; Hypophosphatemia; Magnesium; Magnesium Deficiency; Middle Aged; Osteomalacia; Short Bowel Syndrome; Treatment Outcome; Withholding Treatment | 2017 |
Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK.
Topics: Anemia, Iron-Deficiency; Budgets; Disaccharides; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron-Dextran Complex; Maltose; Retrospective Studies; United Kingdom | 2017 |
Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia.
Topics: Cell Line, Tumor; Cell Proliferation; Cytosine Deaminase; Exosomes; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; HeLa Cells; Humans; Hyperthermia, Induced; Magnetic Fields; Male; Mesenchymal Stem Cells; Nanoparticles; Pentosyltransferases; Prostatic Neoplasms; Recombinant Proteins | 2017 |
Zinc deficiency anaemia in haemodialysis patients: Often overlooked but a treatable cause of anaemia.
Topics: Aged, 80 and over; Anemia; Biomarkers; Carnosine; Darbepoetin alfa; Deficiency Diseases; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Organometallic Compounds; Renal Dialysis; Treatment Outcome; Zinc; Zinc Compounds | 2017 |
Iron sucrose: assessing the similarity between the originator drug and its intended copies.
Topics: Anemia, Iron-Deficiency; Biosimilar Pharmaceuticals; Chemical Phenomena; Chemistry, Pharmaceutical; Drug Approval; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Particle Size; Technology, Pharmaceutical; Therapeutic Equivalency | 2017 |
Influence of Carnicor, Venofer, and Sevelamer on the levels of genotoxic damage in end-stage renal disease patients.
Topics: Carnitine; Chelating Agents; Comet Assay; DNA Damage; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Lymphocytes; Male; Micronucleus Tests; Middle Aged; Neuroprotective Agents; Oxidative Stress; Sevelamer | 2018 |
A robust and easily reproducible protocol for the determination of size and size distribution of iron sucrose using dynamic light scattering.
Topics: Anemia, Iron-Deficiency; Dynamic Light Scattering; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Light; Nanoparticles; Particle Size; Scattering, Radiation | 2018 |
Bioequivalence decision for nanoparticular iron complex drugs for parenteral administration based on their disposition.
Topics: Amylopectin; Animals; Embryo, Nonmammalian; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron-Dextran Complex; Kidney; Liver; Maltose; Models, Animal; Myocardium; Nanoparticles; Therapeutic Equivalency; Turkey | 2018 |
Financial impact of intravenous iron treatments on the management of anaemia inpatients: a 1 year observational study.
Topics: Administration, Intravenous; Aged; Anemia, Iron-Deficiency; Drug Costs; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Inpatients; Length of Stay; Male; Maltose; Middle Aged; Retrospective Studies | 2018 |
Use of iron sucrose injection in anemia patients with reduced serum iron concentration during hospitalizations of digestive and liver diseases.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hospitalization; Humans; Iron; Liver Diseases | 2021 |
Iron Sucrose and Blood Pressure Patterns During Hemodialysis.
Topics: Anemia, Iron-Deficiency; Blood Pressure; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Renal Dialysis | 2023 |
Intravenous iron for critically ill children. Comparison of three dose regimens.
Topics: Anemia; Anemia, Iron-Deficiency; Child; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron; Prospective Studies | 2024 |